ID stringlengths 13 17 | question stringlengths 88 1.13k | answer stringlengths 6 156 | reference_sequence stringlengths 4.1k 4.1k | variant_sequence stringlengths 4.1k 4.1k |
|---|---|---|---|---|
Task1_train_13100 | This sequence change occurs on Chromosome 9, altering MUSK (muscle associated receptor tyrosine kinase). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; not provided | TTAAAGACATGGCTTGGGCTAGGCATGAGGTTTTCTTATGCCCATCCATCTATGCATCCATCCTTAAATCTATCCATGCATCCACCTATGCATTAATTCATCCATCCACCCATCAACATATATTGAAAACCCATAGTGAGCCATGTGTAGTATTAGACCTGAGGTTACAAGGATGAATAAAATACAGTCTTCCTCTCAATAATTATTATATTTTGAAGTCCCACCTAAGAGTTGGGTTGGAGTAATTACAATATAGAAAACATTTTGAGGTCTTAAATAAATGTATATACATATATAATTGTAAATTATATCTATACACA... | TTAAAGACATGGCTTGGGCTAGGCATGAGGTTTTCTTATGCCCATCCATCTATGCATCCATCCTTAAATCTATCCATGCATCCACCTATGCATTAATTCATCCATCCACCCATCAACATATATTGAAAACCCATAGTGAGCCATGTGTAGTATTAGACCTGAGGTTACAAGGATGAATAAAATACAGTCTTCCTCTCAATAATTATTATATTTTGAAGTCCCACCTAAGAGTTGGGTTGGAGTAATTACAATATAGAAAACATTTTGAGGTCTTAAATAAATGTATATACATATATAATTGTAAATTATATCTATACACA... |
Task1_train_13101 | With a mutation on Chromosome 9 in gene SHOC1 (shortage in chiasmata 1), classify this variant as benign or pathogenic. Include the disease if it's pathogenic. | Pathogenic; Spermatogenic failure 75 | TTTGTATTTACTACTCTATCTCCCACTGTTGAAAGTTTGAGAATATATCTGTCCATATATTTTTCATGCCAAAGTTGGAGTCAACCTAAATGTTCATTAGTGAGAGAATGATTAAATATATTATGGCAGATTATATTATGCAGCTGCTAAGAAGAATATGTATTCAGTAGTGCTGCTATAATATGACACAGGCATTCCTAAAAATCACCAAGTTATATCAAATCACACAATAACCACCACAGGGCCTATGGGAAAATGGAGTTGGGACTTAATATTAAAAAATTTTGCCAGTGACAGTAAAAAAGACAGAAACCTAATGA... | TTTGTATTTACTACTCTATCTCCCACTGTTGAAAGTTTGAGAATATATCTGTCCATATATTTTTCATGCCAAAGTTGGAGTCAACCTAAATGTTCATTAGTGAGAGAATGATTAAATATATTATGGCAGATTATATTATGCAGCTGCTAAGAAGAATATGTATTCAGTAGTGCTGCTATAATATGACACAGGCATTCCTAAAAATCACCAAGTTATATCAAATCACACAATAACCACCACAGGGCCTATGGGAAAATGGAGTTGGGACTTAATATTAAAAAATTTTGCCAGTGACAGTAAAAAAGACAGAAACCTAATGA... |
Task1_train_13102 | Here is a genetic alteration in SHOC1 (shortage in chiasmata 1) on Chromosome 9. Based on the data, is it a benign variant or a cause of disease? | Pathogenic; Spermatogenic failure 75 | TAAATAGTAATGCCAAAGTATGATTTAGTAACTGCATGTCTTAGAGGAACAGAAAGAATTCAGTCCAAGTATAAAGCTCTCAGTGGTCTCACTTAACTAGGGTAAATTATAGACTACACTACTTAAAGATAAATATTGTTTAAGCCAACCTCCATAAATATTATTTCTTTCTTTTCTCCCTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACGGAGTTTCACTCTTTTTGCCCAGGCTGGAGTGCAATGGCGCAATCTTGGCTCACTGCAGCCTGTGCCTCGCGGGTTCAAGTGATCCTTCTGCCTCAGCCTCCTGAGTAG... | TAAATAGTAATGCCAAAGTATGATTTAGTAACTGCATGTCTTAGAGGAACAGAAAGAATTCAGTCCAAGTATAAAGCTCTCAGTGGTCTCACTTAACTAGGGTAAATTATAGACTACACTACTTAAAGATAAATATTGTTTAAGCCAACCTCCATAAATATTATTTCTTTCTTTTCTCCCTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACGGAGTTTCACTCTTTTTGCCCAGGCTGGAGTGCAATGGCGCAATCTTGGCTCACTGCAGCCTGTGCCTCGCGGGTTCAAGTGATCCTTCTGCCTCAGCCTCCTGAGTAG... |
Task1_train_13103 | A change on Chromosome 9 affects gene SLC31A1 (solute carrier family 31 member 1). Identify whether the variant is neutral or disease-linked. Mention the disease if applicable. | Pathogenic; Neurodegeneration and seizures due to copper transport defect | GGCATTCGCCTGTAGTCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATCGCTTGAACCCAGGAGGTGGAGGTTGTAGTGAGCCGAGATCTCGCCACTGCATTCCAGCCTGGGCTACAGAGCGAGAATCCGTATCAAAAAAAAAAAAAAAAAAGATAAAAGTTGATGGTGGGGGCCCAGGAGAAAAGTTGATGGTGGGGGCCTAGTAGAATACTCATGCTCGGTGCCTGTGGTGGTAACGCTAACATGAGGGCAAAAGCCTCCCACTCACGTGAATGTCTCTTATTATCCAGATCTTCTACTTTTAAATGTTCTAAGCTTC... | GGCATTCGCCTGTAGTCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATCGCTTGAACCCAGGAGGTGGAGGTTGTAGTGAGCCGAGATCTCGCCACTGCATTCCAGCCTGGGCTACAGAGCGAGAATCCGTATCAAAAAAAAAAAAAAAAAAGATAAAAGTTGATGGTGGGGGCCCAGGAGAAAAGTTGATGGTGGGGGCCTAGTAGAATACTCATGCTCGGTGCCTGTGGTGGTAACGCTAACATGAGGGCAAAAGCCTCCCACTCACGTGAATGTCTCTTATTATCCAGATCTTCTACTTTTAAATGTTCTAAGCTTC... |
Task1_train_13104 | Given a variant located on Chromosome 9 and affecting ALAD (aminolevulinate dehydratase), assess whether it is benign or pathogenic. Indicate the associated disease if pathogenic. | Pathogenic; Porphobilinogen synthase deficiency | TTTACAAACTACAAATTTGATTGAGTCACTCTGAAAAGGTGAATGTGGCCCTTGACCTCTGCATGGTTTGGTCCTGGTCTGTCTCTCTCCACTCAGTTCAGGCCATCCTCTCAGTGCTCCAGACAAGCTAGCCTTGCATTCCTCCAGCTAGAAGGAGCCCCAGGGCCTTTGCACAACTCCTCCCTCTCCCTGGAATGCTCTTCCCCAATTGTCTTAGCTTGATGGCTCACCCTTCAGGTCTAGGCTCAAATGTCAGTCCTTCAGGGAAGTATTTTCTGATCCTTCAAAGAGGTCAGGTCCTGGTGACCTCCTTCAGAGCA... | TTTACAAACTACAAATTTGATTGAGTCACTCTGAAAAGGTGAATGTGGCCCTTGACCTCTGCATGGTTTGGTCCTGGTCTGTCTCTCTCCACTCAGTTCAGGCCATCCTCTCAGTGCTCCAGACAAGCTAGCCTTGCATTCCTCCAGCTAGAAGGAGCCCCAGGGCCTTTGCACAACTCCTCCCTCTCCCTGGAATGCTCTTCCCCAATTGTCTTAGCTTGATGGCTCACCCTTCAGGTCTAGGCTCAAATGTCAGTCCTTCAGGGAAGTATTTTCTGATCCTTCAAAGAGGTCAGGTCCTGGTGACCTCCTTCAGAGCA... |
Task1_train_13105 | Chromosome 9 houses a mutation in gene KIF12 (kinesin family member 12). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Cholestasis, progressive familial intrahepatic, 8 | TGGCCCTGACAGGGCAGGGTGAGGAGGGGGGAGGGTGAGGCAAACAGCTATTTCAAACCAGGGCAGAGGGAGCCCTAGGCCAGCCATTCACTCCCCATGATCTAGCCTGCAGCCCTGGAATCCCTGGGGCTCTGGATTGATGACTCCTGGATCAAGGTCTCCAGTTCTCCCAGCCTTCCCTCACTCCCACCATGGCCTTTCCTACCTGGGGCAGGTGGTGCTCCCCTGGCAGGCAGGCCCAGTGGGCCAGGGGCACTCGACACAGTGGGCAGATGTGGCAGCAGGGGCAGGAGTAGAGGGGTGGCAGTGCCTGCAAAAAG... | TGGCCCTGACAGGGCAGGGTGAGGAGGGGGGAGGGTGAGGCAAACAGCTATTTCAAACCAGGGCAGAGGGAGCCCTAGGCCAGCCATTCACTCCCCATGATCTAGCCTGCAGCCCTGGAATCCCTGGGGCTCTGGATTGATGACTCCTGGATCAAGGTCTCCAGTTCTCCCAGCCTTCCCTCACTCCCACCATGGCCTTTCCTACCTGGGGCAGGTGGTGCTCCCCTGGCAGGCAGGCCCAGTGGGCCAGGGGCACTCGACACAGTGGGCAGATGTGGCAGCAGGGGCAGGAGTAGAGGGGTGGCAGTGCCTGCAAAAAG... |
Task1_train_13106 | A variant has been detected on Chromosome 9 in COL27A1 (collagen type XXVII alpha 1 chain). What is its effect — pathogenic or benign? If pathogenic, name the disease. | Pathogenic; Steel syndrome | GACACATTCCAGCTGTGAACTGAAGAATGTTTGTGGTTTGGCTAACGATGATTGGAGAAGGGGTTTCTAGGTGTGGGTGACTGCCTGAGCAACAGCCTGGTCGCAGGACAGTGTGGGACATGGCTGGGGCGTGGGCTGTGGTTTGAGGATAGAGCAGAGGGACCCTCTCTGTGGGTTTGGCTGCTGAAAGGAGAGCAGAGTCTAGATAGGGTGCCTGGGACTGGCTGGATTACAGAAGACTTGGGATAGCAGAAGGAGGAACTTGGACTTTGTCACCATGCAGTCAGGGGAAGCTGTGGAAGGTGTTAGAGCAGGGGAGT... | GACACATTCCAGCTGTGAACTGAAGAATGTTTGTGGTTTGGCTAACGATGATTGGAGAAGGGGTTTCTAGGTGTGGGTGACTGCCTGAGCAACAGCCTGGTCGCAGGACAGTGTGGGACATGGCTGGGGCGTGGGCTGTGGTTTGAGGATAGAGCAGAGGGACCCTCTCTGTGGGTTTGGCTGCTGAAAGGAGAGCAGAGTCTAGATAGGGTGCCTGGGACTGGCTGGATTACAGAAGACTTGGGATAGCAGAAGGAGGAACTTGGACTTTGTCACCATGCAGTCAGGGGAAGCTGTGGAAGGTGTTAGAGCAGGGGAGT... |
Task1_train_13107 | The gene COL27A1 (collagen type XXVII alpha 1 chain) on Chromosome 9 contains a mutation. Based on this information, is the variant pathogenic or benign? Provide the disease if relevant. | Pathogenic; Steel syndrome | CCCAAAGTTCAGAGGCCAGAGGTGGGAACTCAATGCCTTCAGAAGGTGCCCTGGCTGGACGCCATGGCTCACACCTGTAATCCCAACACTTTGGGAGGCCAAGGCAGGCAGATCGCTTGAGCCCAGGAGTTCGAGACCAGCTTGGGCAACATGGAGAAACCCCATCTTTACCAAAAATACAAAAATTAGCCAGGTGTAGTGGTGTGCATCTGTAATCCCAGCTACTTGGGAGGCTGAGGCGGCAGGATCACTAGGAGGCAGAGGTTGCAGTGAGCAGTTATCACACCACTGCACTTCAGCCTGGATGACAGAGTGAGACC... | CCCAAAGTTCAGAGGCCAGAGGTGGGAACTCAATGCCTTCAGAAGGTGCCCTGGCTGGACGCCATGGCTCACACCTGTAATCCCAACACTTTGGGAGGCCAAGGCAGGCAGATCGCTTGAGCCCAGGAGTTCGAGACCAGCTTGGGCAACATGGAGAAACCCCATCTTTACCAAAAATACAAAAATTAGCCAGGTGTAGTGGTGTGCATCTGTAATCCCAGCTACTTGGGAGGCTGAGGCGGCAGGATCACTAGGAGGCAGAGGTTGCAGTGAGCAGTTATCACACCACTGCACTTCAGCCTGGATGACAGAGTGAGACC... |
Task1_train_13108 | Located on Chromosome 9, this mutation impacts TNC (tenascin C). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any? | Pathogenic; Autosomal dominant nonsyndromic hearing loss 56 | CTCACTGCAACCTCTGCCTCCCGGGTTCAAGCAATGATCCTGCCTCAGCCTCCCAAGTAGCTGGGATTGCAGGTGTGCACCACCAAGCCCAGCTAACTTTTGTATTTTCAGTAGAGATGGGTTTTTTCACCATGTTGGCTAGGCTGGTCTTGAACACCTGACCTCAGGTGATCCACCTTCCTTGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGTCACCGCACCTGGCCCCGAGCCTTTTCTGAGCTTTGAGTGGTATTTCTCCTTAGATGGCTTGCAGAGAACATAAAGCCAGGCTCTGGAGGCCGGTGGTCCCGGG... | CTCACTGCAACCTCTGCCTCCCGGGTTCAAGCAATGATCCTGCCTCAGCCTCCCAAGTAGCTGGGATTGCAGGTGTGCACCACCAAGCCCAGCTAACTTTTGTATTTTCAGTAGAGATGGGTTTTTTCACCATGTTGGCTAGGCTGGTCTTGAACACCTGACCTCAGGTGATCCACCTTCCTTGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGTCACCGCACCTGGCCCCGAGCCTTTTCTGAGCTTTGAGTGGTATTTCTCCTTAGATGGCTTGCAGAGAACATAAAGCCAGGCTCTGGAGGCCGGTGGTCCCGGG... |
Task1_train_13109 | A variant found in Chromosome 9 affects ASTN2, TRIM32 (astrotactin 2| tripartite motif containing 32). Please analyze its biological impact: is it benign or pathogenic, and what condition might it cause? | Pathogenic; Bardet-Biedl syndrome | CCCCACTCCATTCCTGCTTTGATCATATCATCTTCCTGCTTCAAAACATTCATCACCTCACCATGCCCTTGAAAATGACGCTCAAAAATCTCATTTTGGCTCTGAAGACCTTTTATAATTATTCCCCCAATTTACCTTTCCAAGTCTGTTACTCTATTCCCCATATATACTCCCACAGTTTTAATCTAAGGATAATAAAAAAGAGAACTAAAATTCATTAAAGGCTTTTTTGGTGCAGAGCCAAATCTTAGCATTCTATACACTCTATATATTATTTCATTCTTACATTAACTCTGTAAAGACAGTATTTTTCCATTTTA... | CCCCACTCCATTCCTGCTTTGATCATATCATCTTCCTGCTTCAAAACATTCATCACCTCACCATGCCCTTGAAAATGACGCTCAAAAATCTCATTTTGGCTCTGAAGACCTTTTATAATTATTCCCCCAATTTACCTTTCCAAGTCTGTTACTCTATTCCCCATATATACTCCCACAGTTTTAATCTAAGGATAATAAAAAAGAGAACTAAAATTCATTAAAGGCTTTTTTGGTGCAGAGCCAAATCTTAGCATTCTATACACTCTATATATTATTTCATTCTTACATTAACTCTGTAAAGACAGTATTTTTCCATTTTA... |
Task1_train_13110 | Consider a variant on Chromosome 9 in gene ASTN2, TRIM32 (astrotactin 2| tripartite motif containing 32). Determine its clinical classification and disease relevance. | Pathogenic; Bardet-Biedl syndrome | ACTTATTCCTTTTACTGTGCATAATTCTCCTGTGCTTTTCTCTTAGTGTAAATCAGAAGTTGTAAAATTCACCAAATATGAAAATAATCATTAGCTCATTAGCATTTATTACAAGTATACTACTTCCCTGGTGCTATACTAAGCACATCATATTTATCTTGTTACTTAGCCCTTATAATAACCATATAAGGCAGACACCATTATTACTTCTATTTTACAGATGAGTGATGGGGAAAGAGCTTTTGGAAGTTTGAGTTAATTCCTTATGGTCATGCAGCTAAGTAAGTGTCTGAGACTACAGAATCTGAATTATTTCCCAC... | ACTTATTCCTTTTACTGTGCATAATTCTCCTGTGCTTTTCTCTTAGTGTAAATCAGAAGTTGTAAAATTCACCAAATATGAAAATAATCATTAGCTCATTAGCATTTATTACAAGTATACTACTTCCCTGGTGCTATACTAAGCACATCATATTTATCTTGTTACTTAGCCCTTATAATAACCATATAAGGCAGACACCATTATTACTTCTATTTTACAGATGAGTGATGGGGAAAGAGCTTTTGGAAGTTTGAGTTAATTCCTTATGGTCATGCAGCTAAGTAAGTGTCTGAGACTACAGAATCTGAATTATTTCCCAC... |
Task1_train_13111 | This variant lies on Chromosome 9 and affects the gene ASTN2, TRIM32 (astrotactin 2| tripartite motif containing 32). Based on this context, is the mutation pathogenic or benign? If pathogenic, what disease does it cause? | Pathogenic; Myopathy | ACTTATTCCTTTTACTGTGCATAATTCTCCTGTGCTTTTCTCTTAGTGTAAATCAGAAGTTGTAAAATTCACCAAATATGAAAATAATCATTAGCTCATTAGCATTTATTACAAGTATACTACTTCCCTGGTGCTATACTAAGCACATCATATTTATCTTGTTACTTAGCCCTTATAATAACCATATAAGGCAGACACCATTATTACTTCTATTTTACAGATGAGTGATGGGGAAAGAGCTTTTGGAAGTTTGAGTTAATTCCTTATGGTCATGCAGCTAAGTAAGTGTCTGAGACTACAGAATCTGAATTATTTCCCAC... | ACTTATTCCTTTTACTGTGCATAATTCTCCTGTGCTTTTCTCTTAGTGTAAATCAGAAGTTGTAAAATTCACCAAATATGAAAATAATCATTAGCTCATTAGCATTTATTACAAGTATACTACTTCCCTGGTGCTATACTAAGCACATCATATTTATCTTGTTACTTAGCCCTTATAATAACCATATAAGGCAGACACCATTATTACTTCTATTTTACAGATGAGTGATGGGGAAAGAGCTTTTGGAAGTTTGAGTTAATTCCTTATGGTCATGCAGCTAAGTAAGTGTCTGAGACTACAGAATCTGAATTATTTCCCAC... |
Task1_train_13112 | Gene ASTN2, TRIM32 (astrotactin 2| tripartite motif containing 32), found on Chromosome 9, is impacted by this variant. What is the biological outcome — benign or pathogenic? | Pathogenic; Retinal dystrophy | ACTTATTCCTTTTACTGTGCATAATTCTCCTGTGCTTTTCTCTTAGTGTAAATCAGAAGTTGTAAAATTCACCAAATATGAAAATAATCATTAGCTCATTAGCATTTATTACAAGTATACTACTTCCCTGGTGCTATACTAAGCACATCATATTTATCTTGTTACTTAGCCCTTATAATAACCATATAAGGCAGACACCATTATTACTTCTATTTTACAGATGAGTGATGGGGAAAGAGCTTTTGGAAGTTTGAGTTAATTCCTTATGGTCATGCAGCTAAGTAAGTGTCTGAGACTACAGAATCTGAATTATTTCCCAC... | ACTTATTCCTTTTACTGTGCATAATTCTCCTGTGCTTTTCTCTTAGTGTAAATCAGAAGTTGTAAAATTCACCAAATATGAAAATAATCATTAGCTCATTAGCATTTATTACAAGTATACTACTTCCCTGGTGCTATACTAAGCACATCATATTTATCTTGTTACTTAGCCCTTATAATAACCATATAAGGCAGACACCATTATTACTTCTATTTTACAGATGAGTGATGGGGAAAGAGCTTTTGGAAGTTTGAGTTAATTCCTTATGGTCATGCAGCTAAGTAAGTGTCTGAGACTACAGAATCTGAATTATTTCCCAC... |
Task1_train_13113 | Given this variant in gene ASTN2, TRIM32 (astrotactin 2| tripartite motif containing 32) on Chromosome 9, classify it as benign or pathogenic. Include the disorder it may cause if applicable. | Pathogenic; Sarcotubular myopathy | ACTTATTCCTTTTACTGTGCATAATTCTCCTGTGCTTTTCTCTTAGTGTAAATCAGAAGTTGTAAAATTCACCAAATATGAAAATAATCATTAGCTCATTAGCATTTATTACAAGTATACTACTTCCCTGGTGCTATACTAAGCACATCATATTTATCTTGTTACTTAGCCCTTATAATAACCATATAAGGCAGACACCATTATTACTTCTATTTTACAGATGAGTGATGGGGAAAGAGCTTTTGGAAGTTTGAGTTAATTCCTTATGGTCATGCAGCTAAGTAAGTGTCTGAGACTACAGAATCTGAATTATTTCCCAC... | ACTTATTCCTTTTACTGTGCATAATTCTCCTGTGCTTTTCTCTTAGTGTAAATCAGAAGTTGTAAAATTCACCAAATATGAAAATAATCATTAGCTCATTAGCATTTATTACAAGTATACTACTTCCCTGGTGCTATACTAAGCACATCATATTTATCTTGTTACTTAGCCCTTATAATAACCATATAAGGCAGACACCATTATTACTTCTATTTTACAGATGAGTGATGGGGAAAGAGCTTTTGGAAGTTTGAGTTAATTCCTTATGGTCATGCAGCTAAGTAAGTGTCTGAGACTACAGAATCTGAATTATTTCCCAC... |
Task1_train_13114 | Here is a variant affecting ASTN2, TRIM32 (astrotactin 2| tripartite motif containing 32) on Chromosome 9. Please identify whether it is a benign mutation or associated with a disorder. | Pathogenic; Bardet-Biedl syndrome 11 | ACTTATTCCTTTTACTGTGCATAATTCTCCTGTGCTTTTCTCTTAGTGTAAATCAGAAGTTGTAAAATTCACCAAATATGAAAATAATCATTAGCTCATTAGCATTTATTACAAGTATACTACTTCCCTGGTGCTATACTAAGCACATCATATTTATCTTGTTACTTAGCCCTTATAATAACCATATAAGGCAGACACCATTATTACTTCTATTTTACAGATGAGTGATGGGGAAAGAGCTTTTGGAAGTTTGAGTTAATTCCTTATGGTCATGCAGCTAAGTAAGTGTCTGAGACTACAGAATCTGAATTATTTCCCAC... | ACTTATTCCTTTTACTGTGCATAATTCTCCTGTGCTTTTCTCTTAGTGTAAATCAGAAGTTGTAAAATTCACCAAATATGAAAATAATCATTAGCTCATTAGCATTTATTACAAGTATACTACTTCCCTGGTGCTATACTAAGCACATCATATTTATCTTGTTACTTAGCCCTTATAATAACCATATAAGGCAGACACCATTATTACTTCTATTTTACAGATGAGTGATGGGGAAAGAGCTTTTGGAAGTTTGAGTTAATTCCTTATGGTCATGCAGCTAAGTAAGTGTCTGAGACTACAGAATCTGAATTATTTCCCAC... |
Task1_train_13115 | This gene mutation involves CDK5RAP2 (CDK5 regulatory subunit associated protein 2) on Chromosome 9. Is it associated with any clinical condition, or is it benign? | Pathogenic; Microcephaly | GATACTGTCTCAAAAACAAAAAGAATAAAGAAATTCATTCTTAAACTACTATTAAAGAAAGATATCATTAAGTAAGGCGAGGCGCAGTGCCTCACGCCTATAATCCAAGCACTTTGGGAGGCCAAGGCAGGTGGATCACTTGAGGCCAGGAGTTTGAGACCAGCCTGGAGAACATGGGGAAACCCCATCTCTACCAAAAGTACAAAAATTAGCCAGGCGTGCTGGCGTGCACATGTAATCCCAGCTAATCAGGAGGCTGAGGACAGGAATTGCTTGAACCTGGGAGGCAGAGGTTGCAGTAAGCCAAGATTGTGCCACTG... | GATACTGTCTCAAAAACAAAAAGAATAAAGAAATTCATTCTTAAACTACTATTAAAGAAAGATATCATTAAGTAAGGCGAGGCGCAGTGCCTCACGCCTATAATCCAAGCACTTTGGGAGGCCAAGGCAGGTGGATCACTTGAGGCCAGGAGTTTGAGACCAGCCTGGAGAACATGGGGAAACCCCATCTCTACCAAAAGTACAAAAATTAGCCAGGCGTGCTGGCGTGCACATGTAATCCCAGCTAATCAGGAGGCTGAGGACAGGAATTGCTTGAACCTGGGAGGCAGAGGTTGCAGTAAGCCAAGATTGTGCCACTG... |
Task1_train_13116 | This variant lies on Chromosome 9 and affects the gene C5 (complement C5). Based on this context, is the mutation pathogenic or benign? If pathogenic, what disease does it cause? | Pathogenic; Complement component 5 deficiency | TCTCTGGGACTAATTTGTCTTGGATGCAAAATTATGGAACTGTTCACTGGACTCATGTGTAAAATCTGCCGCATCTGTTCTGCACACTAGCCAAAACACATGGTCAAGAGTACACATTGTCCTAGAAAATACAACAGGAGAATTCAGCTCACATTAAACTCCAGCACCGTCACTCCAGATGGGAGATTAAGCACAAAGGAAGCTACTCCATCATCAACACGTGTTACACTTTTGCTTGGATCCAAGTCAGATGTCTCTTGGTTTACATCAATTGTTTGTGCATTCAGTGTTACTGGGACTCCTCCTACCAACTGGTCAAG... | TCTCTGGGACTAATTTGTCTTGGATGCAAAATTATGGAACTGTTCACTGGACTCATGTGTAAAATCTGCCGCATCTGTTCTGCACACTAGCCAAAACACATGGTCAAGAGTACACATTGTCCTAGAAAATACAACAGGAGAATTCAGCTCACATTAAACTCCAGCACCGTCACTCCAGATGGGAGATTAAGCACAAAGGAAGCTACTCCATCATCAACACGTGTTACACTTTTGCTTGGATCCAAGTCAGATGTCTCTTGGTTTACATCAATTGTTTGTGCATTCAGTGTTACTGGGACTCCTCCTACCAACTGGTCAAG... |
Task1_train_13117 | This mutation occurs in GSN (gelsolin) on Chromosome 9. Does this change lead to a known medical condition, or is it benign? | Pathogenic; Finnish type amyloidosis | CTGTGGGCCCCATTTTGCACATCAGTGCGATGCAGCAATGACACCTCCCTTGCAGGCGATGCGTGAAGAATGCCCGGCACAGTGGGCATCATCATTTCACAAACACGTATACTGCTGACACAGGAAGACAGAGCAGGAGCCCAATATACACGGACTCCGTTTGTCCCTTGCCCTCCTCGAGTCTGTGCGGCTAGAATTAGACTTAGCACAGTGGGCTGAGGGGCCCTGGATGGGGTGGCTGCATTGCTGGCCTGAGTGGAAGCCCTCTGCTTCCACCCCCATGTGTCTCCGGAGCAGGGAGACGAGCACCCGATTGGGAG... | CTGTGGGCCCCATTTTGCACATCAGTGCGATGCAGCAATGACACCTCCCTTGCAGGCGATGCGTGAAGAATGCCCGGCACAGTGGGCATCATCATTTCACAAACACGTATACTGCTGACACAGGAAGACAGAGCAGGAGCCCAATATACACGGACTCCGTTTGTCCCTTGCCCTCCTCGAGTCTGTGCGGCTAGAATTAGACTTAGCACAGTGGGCTGAGGGGCCCTGGATGGGGTGGCTGCATTGCTGGCCTGAGTGGAAGCCCTCTGCTTCCACCCCCATGTGTCTCCGGAGCAGGGAGACGAGCACCCGATTGGGAG... |
Task1_train_13118 | This variant affects the gene GSN (gelsolin) found on Chromosome 9. What is the clinical effect of this variant — benign or pathogenic? State the disease if applicable. | Pathogenic; Finnish type amyloidosis | CCCCATTTTGCACATCAGTGCGATGCAGCAATGACACCTCCCTTGCAGGCGATGCGTGAAGAATGCCCGGCACAGTGGGCATCATCATTTCACAAACACGTATACTGCTGACACAGGAAGACAGAGCAGGAGCCCAATATACACGGACTCCGTTTGTCCCTTGCCCTCCTCGAGTCTGTGCGGCTAGAATTAGACTTAGCACAGTGGGCTGAGGGGCCCTGGATGGGGTGGCTGCATTGCTGGCCTGAGTGGAAGCCCTCTGCTTCCACCCCCATGTGTCTCCGGAGCAGGGAGACGAGCACCCGATTGGGAGGAGGAAA... | CCCCATTTTGCACATCAGTGCGATGCAGCAATGACACCTCCCTTGCAGGCGATGCGTGAAGAATGCCCGGCACAGTGGGCATCATCATTTCACAAACACGTATACTGCTGACACAGGAAGACAGAGCAGGAGCCCAATATACACGGACTCCGTTTGTCCCTTGCCCTCCTCGAGTCTGTGCGGCTAGAATTAGACTTAGCACAGTGGGCTGAGGGGCCCTGGATGGGGTGGCTGCATTGCTGGCCTGAGTGGAAGCCCTCTGCTTCCACCCCCATGTGTCTCCGGAGCAGGGAGACGAGCACCCGATTGGGAGGAGGAAA... |
Task1_train_13119 | This variant affects gene GSN (gelsolin) located on Chromosome 9. Evaluate its biological effect and specify any disease association. | Pathogenic; Inborn genetic diseases | CCCCATTTTGCACATCAGTGCGATGCAGCAATGACACCTCCCTTGCAGGCGATGCGTGAAGAATGCCCGGCACAGTGGGCATCATCATTTCACAAACACGTATACTGCTGACACAGGAAGACAGAGCAGGAGCCCAATATACACGGACTCCGTTTGTCCCTTGCCCTCCTCGAGTCTGTGCGGCTAGAATTAGACTTAGCACAGTGGGCTGAGGGGCCCTGGATGGGGTGGCTGCATTGCTGGCCTGAGTGGAAGCCCTCTGCTTCCACCCCCATGTGTCTCCGGAGCAGGGAGACGAGCACCCGATTGGGAGGAGGAAA... | CCCCATTTTGCACATCAGTGCGATGCAGCAATGACACCTCCCTTGCAGGCGATGCGTGAAGAATGCCCGGCACAGTGGGCATCATCATTTCACAAACACGTATACTGCTGACACAGGAAGACAGAGCAGGAGCCCAATATACACGGACTCCGTTTGTCCCTTGCCCTCCTCGAGTCTGTGCGGCTAGAATTAGACTTAGCACAGTGGGCTGAGGGGCCCTGGATGGGGTGGCTGCATTGCTGGCCTGAGTGGAAGCCCTCTGCTTCCACCCCCATGTGTCTCCGGAGCAGGGAGACGAGCACCCGATTGGGAGGAGGAAA... |
Task1_train_13120 | This sequence variant lies in GSN (gelsolin) on Chromosome 9. Is it clinically significant, and what condition might it cause if any? | Pathogenic; Finnish type amyloidosis | TTCCAGGAGGGACTCGCTATGTTCGGAAAGGAGGGAGCTATCCCAGGGGGCTAGTGCTGATGGCATCCCCAGGGAGGGGCCTTGAATGCCAATTTCAAGGGTGTAGACTTGATCCTCTAACCAGTGGGTGCTAGTGAGGGGTTTTTCTTTTTATTAAATCAGACATGCAACAGGCTCAGATTTATGCTTTATCTTTTTTTTTTTTTTTAATAGAGACAGGGTCTCGCTATGTTGCCCGGGCTAATTTCAAACTCCTGGGCTCAAGCAATCCTCCTGCCTCGGCCCCCCAAAGTGTTGGAATTACAGGCATGAGCCACTGC... | TTCCAGGAGGGACTCGCTATGTTCGGAAAGGAGGGAGCTATCCCAGGGGGCTAGTGCTGATGGCATCCCCAGGGAGGGGCCTTGAATGCCAATTTCAAGGGTGTAGACTTGATCCTCTAACCAGTGGGTGCTAGTGAGGGGTTTTTCTTTTTATTAAATCAGACATGCAACAGGCTCAGATTTATGCTTTATCTTTTTTTTTTTTTTTAATAGAGACAGGGTCTCGCTATGTTGCCCGGGCTAATTTCAAACTCCTGGGCTCAAGCAATCCTCCTGCCTCGGCCCCCCAAAGTGTTGGAATTACAGGCATGAGCCACTGC... |
Task1_train_13121 | This mutation is located in gene NDUFA8 (NADH:ubiquinone oxidoreductase subunit A8) on Chromosome 9. Is it associated with a disease or is it a benign polymorphism? | Pathogenic; Mitochondrial complex 1 deficiency, nuclear type 37 | AAAAACAAAAAAAATGTTGCCCAGGCTAGTCCTGAACTCGTGAGCTCAAGCGATCCTCCTGCCTCAGCCTCCCAAAGTGCTAGAATTGCAGGTGTGAGCCATGGCACCTGATCGAGAAATACACTTTTGAAAAGAGTTAAGAGAATTTTTTTTTTATCTCACAGAGTTTTAAAAAATGTTAATACAAAGATTCAAGAATAAATATGCTTTCTTACTAGCATGACTTGTTATTTCTTCTTTCATAAGTCAGAAATGAGAAAAGGTAGTTTTATTTGTTACATGTATAAGTTCTACCACTTTCCAATCTAGAATTATCAACT... | AAAAACAAAAAAAATGTTGCCCAGGCTAGTCCTGAACTCGTGAGCTCAAGCGATCCTCCTGCCTCAGCCTCCCAAAGTGCTAGAATTGCAGGTGTGAGCCATGGCACCTGATCGAGAAATACACTTTTGAAAAGAGTTAAGAGAATTTTTTTTTTATCTCACAGAGTTTTAAAAAATGTTAATACAAAGATTCAAGAATAAATATGCTTTCTTACTAGCATGACTTGTTATTTCTTCTTTCATAAGTCAGAAATGAGAAAAGGTAGTTTTATTTGTTACATGTATAAGTTCTACCACTTTCCAATCTAGAATTATCAACT... |
Task1_train_13122 | A genetic alteration is present in NDUFA8 (NADH:ubiquinone oxidoreductase subunit A8) on Chromosome 9. Is this variant benign or disease-causing, and if the latter, which condition is involved? | Pathogenic; Mitochondrial complex 1 deficiency, nuclear type 37 | GGTACTGGGTGCCCTATAGTCCTAGCTACTCGGGAGGCTGAGGCAGGAGAATGGCGCGAACCCGGGAGGCGGAGCTTGCAGTAAGCCAAGATCGTGCTACTGCACTCCAGCCTGGGCGACAGAGTGACACCCCATCACAAAAAAAAAAAAAAAAAAAAAAAAAAAGCAATACAGTTCAAGAGCCATAATGATGTTCAAAGCCCTTTATAGAGTAAACTCACTGTTAGGAAATTTATGCCAAGGAATTATTAACTGATGAAAATGATCTATACGCAAAGGTAATCACTGCAGATTTATCCAAAATAATCAAAAACTGAAAT... | GGTACTGGGTGCCCTATAGTCCTAGCTACTCGGGAGGCTGAGGCAGGAGAATGGCGCGAACCCGGGAGGCGGAGCTTGCAGTAAGCCAAGATCGTGCTACTGCACTCCAGCCTGGGCGACAGAGTGACACCCCATCACAAAAAAAAAAAAAAAAAAAAAAAAAAAGCAATACAGTTCAAGAGCCATAATGATGTTCAAAGCCCTTTATAGAGTAAACTCACTGTTAGGAAATTTATGCCAAGGAATTATTAACTGATGAAAATGATCTATACGCAAAGGTAATCACTGCAGATTTATCCAAAATAATCAAAAACTGAAAT... |
Task1_train_13123 | A mutation in CRB2 (crumbs cell polarity complex component 2), located on Chromosome 9, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; Focal segmental glomerulosclerosis 9 | GGCAATGGAGCCGGGGGCTCTGTGGACCTTCCTGGGCCACCTGTGGCTCCTGGCAGGTATGGAGGAATGTGGGCCCTGGGCAGGGGGAGGTTGGTGGGTGGTGGTTCCTAGGAAGAGGCTGTGGTGTTTGTGAGCTGATCGAGGCTGGGCTTCAAACCCTGGTGACTTCTCTGGGCCTGGGTTCCTCCAGCTGGGATGTGGCTCTGGCTGAGCTACAGTGGGCTATGGCTTCTGGACCCAAGCTGGGGCCTGAGCACCTGAAGGGATCCCTAGAGGGAGGATGAGGCAGCCCCTTCACAGCCAGTGTGGGGGCCCTGGGG... | GGCAATGGAGCCGGGGGCTCTGTGGACCTTCCTGGGCCACCTGTGGCTCCTGGCAGGTATGGAGGAATGTGGGCCCTGGGCAGGGGGAGGTTGGTGGGTGGTGGTTCCTAGGAAGAGGCTGTGGTGTTTGTGAGCTGATCGAGGCTGGGCTTCAAACCCTGGTGACTTCTCTGGGCCTGGGTTCCTCCAGCTGGGATGTGGCTCTGGCTGAGCTACAGTGGGCTATGGCTTCTGGACCCAAGCTGGGGCCTGAGCACCTGAAGGGATCCCTAGAGGGAGGATGAGGCAGCCCCTTCACAGCCAGTGTGGGGGCCCTGGGG... |
Task1_train_13124 | A variant has been detected on Chromosome 9 in CRB2 (crumbs cell polarity complex component 2). What is its effect — pathogenic or benign? If pathogenic, name the disease. | Pathogenic; Ventriculomegaly-cystic kidney disease | CGGGGGCTCTGTGGACCTTCCTGGGCCACCTGTGGCTCCTGGCAGGTATGGAGGAATGTGGGCCCTGGGCAGGGGGAGGTTGGTGGGTGGTGGTTCCTAGGAAGAGGCTGTGGTGTTTGTGAGCTGATCGAGGCTGGGCTTCAAACCCTGGTGACTTCTCTGGGCCTGGGTTCCTCCAGCTGGGATGTGGCTCTGGCTGAGCTACAGTGGGCTATGGCTTCTGGACCCAAGCTGGGGCCTGAGCACCTGAAGGGATCCCTAGAGGGAGGATGAGGCAGCCCCTTCACAGCCAGTGTGGGGGCCCTGGGGCAGAGGGACTG... | CGGGGGCTCTGTGGACCTTCCTGGGCCACCTGTGGCTCCTGGCAGGTATGGAGGAATGTGGGCCCTGGGCAGGGGGAGGTTGGTGGGTGGTGGTTCCTAGGAAGAGGCTGTGGTGTTTGTGAGCTGATCGAGGCTGGGCTTCAAACCCTGGTGACTTCTCTGGGCCTGGGTTCCTCCAGCTGGGATGTGGCTCTGGCTGAGCTACAGTGGGCTATGGCTTCTGGACCCAAGCTGGGGCCTGAGCACCTGAAGGGATCCCTAGAGGGAGGATGAGGCAGCCCCTTCACAGCCAGTGTGGGGGCCCTGGGGCAGAGGGACTG... |
Task1_train_13125 | The gene NR5A1 (nuclear receptor subfamily 5 group A member 1) is located on Chromosome 9, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; 46,XY sex reversal 3 | GCTCTGAGGGGTCTGGTCTCCCAGGTCTGTGGCTCATGGGCCCTTGGCAAGTGCCTTCCCCTCCTAGAGTATAACCCCTGCCTCACAGGGCTGCTGCGGGGACAGTGAGATGAGGGTGGCACACAGTAGGTGCCCCTTAAATGGCTGCTCCTTCTGCCCCAAGATGGGGGCTGAGCTGGCATGGCCAGCATGCAACAGGCAGAGAGGCTACAGCATCCCCCTGGCCTCCCAGTGCCTCAGGGTCCCAGGGATGAGGTGGGTCCCAAACCCCAACAGTGCCTGGTGTCCCCCCACCCGGCCCCGCCACCCACCTGCCTCCT... | GCTCTGAGGGGTCTGGTCTCCCAGGTCTGTGGCTCATGGGCCCTTGGCAAGTGCCTTCCCCTCCTAGAGTATAACCCCTGCCTCACAGGGCTGCTGCGGGGACAGTGAGATGAGGGTGGCACACAGTAGGTGCCCCTTAAATGGCTGCTCCTTCTGCCCCAAGATGGGGGCTGAGCTGGCATGGCCAGCATGCAACAGGCAGAGAGGCTACAGCATCCCCCTGGCCTCCCAGTGCCTCAGGGTCCCAGGGATGAGGTGGGTCCCAAACCCCAACAGTGCCTGGTGTCCCCCCACCCGGCCCCGCCACCCACCTGCCTCCT... |
Task1_train_13126 | Mutation context: Chromosome 9, Gene NR5A1 (nuclear receptor subfamily 5 group A member 1). Determine if this variant is likely to be benign or pathogenic. Mention the disease if applicable. | Pathogenic; Disorder of sexual differentiation | GGGCTGCTGCGGGGACAGTGAGATGAGGGTGGCACACAGTAGGTGCCCCTTAAATGGCTGCTCCTTCTGCCCCAAGATGGGGGCTGAGCTGGCATGGCCAGCATGCAACAGGCAGAGAGGCTACAGCATCCCCCTGGCCTCCCAGTGCCTCAGGGTCCCAGGGATGAGGTGGGTCCCAAACCCCAACAGTGCCTGGTGTCCCCCCACCCGGCCCCGCCACCCACCTGCCTCCTCAGAGTTTTGAAGCAAAGAGGGTCTGCGTGCCACCTCCATCCAAGTCAGAGCGCTGCCCCAACCTAGACCACCCGGAATCCACCCGG... | GGGCTGCTGCGGGGACAGTGAGATGAGGGTGGCACACAGTAGGTGCCCCTTAAATGGCTGCTCCTTCTGCCCCAAGATGGGGGCTGAGCTGGCATGGCCAGCATGCAACAGGCAGAGAGGCTACAGCATCCCCCTGGCCTCCCAGTGCCTCAGGGTCCCAGGGATGAGGTGGGTCCCAAACCCCAACAGTGCCTGGTGTCCCCCCACCCGGCCCCGCCACCCACCTGCCTCCTCAGAGTTTTGAAGCAAAGAGGGTCTGCGTGCCACCTCCATCCAAGTCAGAGCGCTGCCCCAACCTAGACCACCCGGAATCCACCCGG... |
Task1_train_13127 | The gene NR5A1 (nuclear receptor subfamily 5 group A member 1), on Chromosome 9, contains a mutation. Does this mutation cause a disorder, or is it a benign change? | Pathogenic; 46,XY sex reversal 3 | GACAGTGAGATGAGGGTGGCACACAGTAGGTGCCCCTTAAATGGCTGCTCCTTCTGCCCCAAGATGGGGGCTGAGCTGGCATGGCCAGCATGCAACAGGCAGAGAGGCTACAGCATCCCCCTGGCCTCCCAGTGCCTCAGGGTCCCAGGGATGAGGTGGGTCCCAAACCCCAACAGTGCCTGGTGTCCCCCCACCCGGCCCCGCCACCCACCTGCCTCCTCAGAGTTTTGAAGCAAAGAGGGTCTGCGTGCCACCTCCATCCAAGTCAGAGCGCTGCCCCAACCTAGACCACCCGGAATCCACCCGGGCCGTTCTGCTTT... | GACAGTGAGATGAGGGTGGCACACAGTAGGTGCCCCTTAAATGGCTGCTCCTTCTGCCCCAAGATGGGGGCTGAGCTGGCATGGCCAGCATGCAACAGGCAGAGAGGCTACAGCATCCCCCTGGCCTCCCAGTGCCTCAGGGTCCCAGGGATGAGGTGGGTCCCAAACCCCAACAGTGCCTGGTGTCCCCCCACCCGGCCCCGCCACCCACCTGCCTCCTCAGAGTTTTGAAGCAAAGAGGGTCTGCGTGCCACCTCCATCCAAGTCAGAGCGCTGCCCCAACCTAGACCACCCGGAATCCACCCGGGCCGTTCTGCTTT... |
Task1_train_13128 | Chromosome 9 houses a mutation in gene NR5A1 (nuclear receptor subfamily 5 group A member 1). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Non-obstructive azoospermia | GCTATGCACAGGGCTTTGGTGGGAAGAGGGGCTGGGGGCCAAGACAATGTCCCTGCCCTTCAGGGGACACCCAAGGACAGACAGAGCCCTGGCAAAGGAGCCTGCTGGCTGATAGCCCACCCTCCACCTACCCCTCCTTAAGGCCCTCCCAGTGGCCTTGTGATGGCAGCCAGGTCAAGAACTCTCACCTTACAAACCACCCGGACTCCCGCGGACACACACTCCAATTCTAGGTGCCTCCAAGCACCACCCTTCCCCACAAATTACTCATGTTCCCAGATCTCCCGGTCCATCCCCAGTCACACACAAACTCTTCACAC... | GCTATGCACAGGGCTTTGGTGGGAAGAGGGGCTGGGGGCCAAGACAATGTCCCTGCCCTTCAGGGGACACCCAAGGACAGACAGAGCCCTGGCAAAGGAGCCTGCTGGCTGATAGCCCACCCTCCACCTACCCCTCCTTAAGGCCCTCCCAGTGGCCTTGTGATGGCAGCCAGGTCAAGAACTCTCACCTTACAAACCACCCGGACTCCCGCGGACACACACTCCAATTCTAGGTGCCTCCAAGCACCACCCTTCCCCACAAATTACTCATGTTCCCAGATCTCCCGGTCCATCCCCAGTCACACACAAACTCTTCACAC... |
Task1_train_13129 | The gene NR5A1 (nuclear receptor subfamily 5 group A member 1) on Chromosome 9 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; Male infertility | GCTATGCACAGGGCTTTGGTGGGAAGAGGGGCTGGGGGCCAAGACAATGTCCCTGCCCTTCAGGGGACACCCAAGGACAGACAGAGCCCTGGCAAAGGAGCCTGCTGGCTGATAGCCCACCCTCCACCTACCCCTCCTTAAGGCCCTCCCAGTGGCCTTGTGATGGCAGCCAGGTCAAGAACTCTCACCTTACAAACCACCCGGACTCCCGCGGACACACACTCCAATTCTAGGTGCCTCCAAGCACCACCCTTCCCCACAAATTACTCATGTTCCCAGATCTCCCGGTCCATCCCCAGTCACACACAAACTCTTCACAC... | GCTATGCACAGGGCTTTGGTGGGAAGAGGGGCTGGGGGCCAAGACAATGTCCCTGCCCTTCAGGGGACACCCAAGGACAGACAGAGCCCTGGCAAAGGAGCCTGCTGGCTGATAGCCCACCCTCCACCTACCCCTCCTTAAGGCCCTCCCAGTGGCCTTGTGATGGCAGCCAGGTCAAGAACTCTCACCTTACAAACCACCCGGACTCCCGCGGACACACACTCCAATTCTAGGTGCCTCCAAGCACCACCCTTCCCCACAAATTACTCATGTTCCCAGATCTCCCGGTCCATCCCCAGTCACACACAAACTCTTCACAC... |
Task1_train_13130 | Assess the clinical impact of this variant on gene NR5A1 (nuclear receptor subfamily 5 group A member 1), found on Chromosome 9. State whether it’s pathogenic or benign, and the disease if applicable. | Pathogenic; 46,XY sex reversal 3 | TGCACAGGGCTTTGGTGGGAAGAGGGGCTGGGGGCCAAGACAATGTCCCTGCCCTTCAGGGGACACCCAAGGACAGACAGAGCCCTGGCAAAGGAGCCTGCTGGCTGATAGCCCACCCTCCACCTACCCCTCCTTAAGGCCCTCCCAGTGGCCTTGTGATGGCAGCCAGGTCAAGAACTCTCACCTTACAAACCACCCGGACTCCCGCGGACACACACTCCAATTCTAGGTGCCTCCAAGCACCACCCTTCCCCACAAATTACTCATGTTCCCAGATCTCCCGGTCCATCCCCAGTCACACACAAACTCTTCACACAGGC... | TGCACAGGGCTTTGGTGGGAAGAGGGGCTGGGGGCCAAGACAATGTCCCTGCCCTTCAGGGGACACCCAAGGACAGACAGAGCCCTGGCAAAGGAGCCTGCTGGCTGATAGCCCACCCTCCACCTACCCCTCCTTAAGGCCCTCCCAGTGGCCTTGTGATGGCAGCCAGGTCAAGAACTCTCACCTTACAAACCACCCGGACTCCCGCGGACACACACTCCAATTCTAGGTGCCTCCAAGCACCACCCTTCCCCACAAATTACTCATGTTCCCAGATCTCCCGGTCCATCCCCAGTCACACACAAACTCTTCACACAGGC... |
Task1_train_13131 | Located on Chromosome 9, this mutation impacts NR5A1 (nuclear receptor subfamily 5 group A member 1). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any? | Pathogenic; 46,XY sex reversal 3 | GCCACAGCAGGGCTACCTCTCCAGCCTCACCCACCCTCCCACCCACCCGCCTCTGGCTGTCTCCACCTCTCTGTCACTGGAGCTGCACTCACCCAGGCTGAAGAGGATGATGAACTTGAGGCAGACAAACTCCTGCCGGTCCAGCTGCAGCGCAAGCAGCTGCAGCACCAGCTCCTGCGCCCGCAACACCAGGCTGTGCAGCAGCGAGCCCGCCTGGGTGGCCACTGTGGTCAGCTCCACCTGGGGGCAGAGGGCACGGGGCGGGGGACAGTCAGAGGACGTGGGTCCGGGCAGGTGGCTCTCTGATGGGGGATGCAGGG... | GCCACAGCAGGGCTACCTCTCCAGCCTCACCCACCCTCCCACCCACCCGCCTCTGGCTGTCTCCACCTCTCTGTCACTGGAGCTGCACTCACCCAGGCTGAAGAGGATGATGAACTTGAGGCAGACAAACTCCTGCCGGTCCAGCTGCAGCGCAAGCAGCTGCAGCACCAGCTCCTGCGCCCGCAACACCAGGCTGTGCAGCAGCGAGCCCGCCTGGGTGGCCACTGTGGTCAGCTCCACCTGGGGGCAGAGGGCACGGGGCGGGGGACAGTCAGAGGACGTGGGTCCGGGCAGGTGGCTCTCTGATGGGGGATGCAGGG... |
Task1_train_13132 | This mutation is located in gene NR5A1 (nuclear receptor subfamily 5 group A member 1) on Chromosome 9. Is it associated with a disease or is it a benign polymorphism? | Pathogenic; Premature ovarian failure 7 | ATGATGAACTTGAGGCAGACAAACTCCTGCCGGTCCAGCTGCAGCGCAAGCAGCTGCAGCACCAGCTCCTGCGCCCGCAACACCAGGCTGTGCAGCAGCGAGCCCGCCTGGGTGGCCACTGTGGTCAGCTCCACCTGGGGGCAGAGGGCACGGGGCGGGGGACAGTCAGAGGACGTGGGTCCGGGCAGGTGGCTCTCTGATGGGGGATGCAGGGCTGAGGGCATGGATTGGAGGTGCAGGTCAGATGGGCTGGCGTCAGGAGGGCCCAGCCTTGGTGCCGAGCCAGGCACGGGTAACATCTGCACAGCCCCGGGGACGCT... | ATGATGAACTTGAGGCAGACAAACTCCTGCCGGTCCAGCTGCAGCGCAAGCAGCTGCAGCACCAGCTCCTGCGCCCGCAACACCAGGCTGTGCAGCAGCGAGCCCGCCTGGGTGGCCACTGTGGTCAGCTCCACCTGGGGGCAGAGGGCACGGGGCGGGGGACAGTCAGAGGACGTGGGTCCGGGCAGGTGGCTCTCTGATGGGGGATGCAGGGCTGAGGGCATGGATTGGAGGTGCAGGTCAGATGGGCTGGCGTCAGGAGGGCCCAGCCTTGGTGCCGAGCCAGGCACGGGTAACATCTGCACAGCCCCGGGGACGCT... |
Task1_train_13133 | The variant affects gene NR5A1 (nuclear receptor subfamily 5 group A member 1), which is on Chromosome 9. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; 46,XY sex reversal 3 | ATGATGAACTTGAGGCAGACAAACTCCTGCCGGTCCAGCTGCAGCGCAAGCAGCTGCAGCACCAGCTCCTGCGCCCGCAACACCAGGCTGTGCAGCAGCGAGCCCGCCTGGGTGGCCACTGTGGTCAGCTCCACCTGGGGGCAGAGGGCACGGGGCGGGGGACAGTCAGAGGACGTGGGTCCGGGCAGGTGGCTCTCTGATGGGGGATGCAGGGCTGAGGGCATGGATTGGAGGTGCAGGTCAGATGGGCTGGCGTCAGGAGGGCCCAGCCTTGGTGCCGAGCCAGGCACGGGTAACATCTGCACAGCCCCGGGGACGCT... | ATGATGAACTTGAGGCAGACAAACTCCTGCCGGTCCAGCTGCAGCGCAAGCAGCTGCAGCACCAGCTCCTGCGCCCGCAACACCAGGCTGTGCAGCAGCGAGCCCGCCTGGGTGGCCACTGTGGTCAGCTCCACCTGGGGGCAGAGGGCACGGGGCGGGGGACAGTCAGAGGACGTGGGTCCGGGCAGGTGGCTCTCTGATGGGGGATGCAGGGCTGAGGGCATGGATTGGAGGTGCAGGTCAGATGGGCTGGCGTCAGGAGGGCCCAGCCTTGGTGCCGAGCCAGGCACGGGTAACATCTGCACAGCCCCGGGGACGCT... |
Task1_train_13134 | The gene NR5A1 (nuclear receptor subfamily 5 group A member 1), on Chromosome 9, contains a mutation. Does this mutation cause a disorder, or is it a benign change? | Pathogenic; ADRENAL INSUFFICIENCY, NR5A1-RELATED | CTAGAAGAGACGCCGGAGTCACCCACACCCCTCCCACTTTTCTGTCTCCTCACCTCTGGACTTTGCAAAGAGACACCAGCCCAGGGTCCACTGGACCAGTGGAAAAGAACTTCCACATGGCTTACGAGAGGCGCTCTAAGGGCTGGGCTGGTACTTATCTGCAAGGCCCCTTTAGAGAAGCTGGTGACCACTGCTCATAATCCCGGGCTCAATTCAAAGACTTTGAGAAGGGGAAGCAGGAAGGTTTGGACCACGGAGAAGCCAGAAGCAGGAAAAAACACTCAGCAAAGCTGGGACAAAAGCCCTTCCCATCCTGCGTG... | CTAGAAGAGACGCCGGAGTCACCCACACCCCTCCCACTTTTCTGTCTCCTCACCTCTGGACTTTGCAAAGAGACACCAGCCCAGGGTCCACTGGACCAGTGGAAAAGAACTTCCACATGGCTTACGAGAGGCGCTCTAAGGGCTGGGCTGGTACTTATCTGCAAGGCCCCTTTAGAGAAGCTGGTGACCACTGCTCATAATCCCGGGCTCAATTCAAAGACTTTGAGAAGGGGAAGCAGGAAGGTTTGGACCACGGAGAAGCCAGAAGCAGGAAAAAACACTCAGCAAAGCTGGGACAAAAGCCCTTCCCATCCTGCGTG... |
Task1_train_13135 | Given this variant in gene NR5A1 (nuclear receptor subfamily 5 group A member 1) on Chromosome 9, classify it as benign or pathogenic. Include the disorder it may cause if applicable. | Pathogenic; Spermatogenic failure 8 | GCGCTCTAAGGGCTGGGCTGGTACTTATCTGCAAGGCCCCTTTAGAGAAGCTGGTGACCACTGCTCATAATCCCGGGCTCAATTCAAAGACTTTGAGAAGGGGAAGCAGGAAGGTTTGGACCACGGAGAAGCCAGAAGCAGGAAAAAACACTCAGCAAAGCTGGGACAAAAGCCCTTCCCATCCTGCGTGAAAATCCCCGGGAGACTAGGAAGGCAGCCAGAGGAAGTGCCCTGCCCCTCAATCCAGGGTTCTGGAAGGCCGGGAATGCCCTGCTCCTCCTCCCCTCTGCACGGGGGGTGCATGGGAAGTCTGGAGGGAA... | GCGCTCTAAGGGCTGGGCTGGTACTTATCTGCAAGGCCCCTTTAGAGAAGCTGGTGACCACTGCTCATAATCCCGGGCTCAATTCAAAGACTTTGAGAAGGGGAAGCAGGAAGGTTTGGACCACGGAGAAGCCAGAAGCAGGAAAAAACACTCAGCAAAGCTGGGACAAAAGCCCTTCCCATCCTGCGTGAAAATCCCCGGGAGACTAGGAAGGCAGCCAGAGGAAGTGCCCTGCCCCTCAATCCAGGGTTCTGGAAGGCCGGGAATGCCCTGCTCCTCCTCCCCTCTGCACGGGGGGTGCATGGGAAGTCTGGAGGGAA... |
Task1_train_13136 | A mutation on Chromosome 9 affecting NR5A1 (nuclear receptor subfamily 5 group A member 1) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Spermatogenic failure 8 | TCCAGGGTTCTGGAAGGCCGGGAATGCCCTGCTCCTCCTCCCCTCTGCACGGGGGGTGCATGGGAAGTCTGGAGGGAAGCTAGCAACCAACCCAAGATGCTTGGGGTCCTCATCCCCACCAGGGCCTCCAGCCATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCAT... | TCCAGGGTTCTGGAAGGCCGGGAATGCCCTGCTCCTCCTCCCCTCTGCACGGGGGGTGCATGGGAAGTCTGGAGGGAAGCTAGCAACCAACCCAAGATGCTTGGGGTCCTCATCCCCACCAGGGCCTCCAGCCATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCAT... |
Task1_train_13137 | This genomic variant is located on Chromosome 9, within the NR5A1 (nuclear receptor subfamily 5 group A member 1) gene. Can you determine its pathogenicity and name any linked disease? | Pathogenic; 46,XY sex reversal 3 | ACCAGGGCCTCCAGCCATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATG... | ACCAGGGCCTCCAGCCATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATG... |
Task1_train_13138 | Gene NR5A1 (nuclear receptor subfamily 5 group A member 1) on Chromosome 9 is altered by this variant. Does this mutation result in a disease or is it benign? | Pathogenic; ADRENAL INSUFFICIENCY, NR5A1-RELATED | ACCAGGGCCTCCAGCCATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATG... | ACCAGGGCCTCCAGCCATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATG... |
Task1_train_13139 | A variant found in Chromosome 9 affects NR5A1 (nuclear receptor subfamily 5 group A member 1). Please analyze its biological impact: is it benign or pathogenic, and what condition might it cause? | Pathogenic; 46,XX sex reversal 4 | ACCAGGGCCTCCAGCCATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATG... | ACCAGGGCCTCCAGCCATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATG... |
Task1_train_13140 | This is a variant in NR5A1 (nuclear receptor subfamily 5 group A member 1), located on Chromosome 9. Is this mutation a likely cause of disease or not? | Pathogenic; not provided | GGGCCTCCAGCCATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATGCCCC... | GGGCCTCCAGCCATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATGCCCC... |
Task1_train_13141 | This genomic variant is located on Chromosome 9, within the NR5A1 (nuclear receptor subfamily 5 group A member 1) gene. Can you determine its pathogenicity and name any linked disease? | Pathogenic; 46,XY sex reversal 3 | ATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATGCCCCTGGAGGAAGCCC... | ATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATGCCCCTGGAGGAAGCCC... |
Task1_train_13142 | The gene NR5A1 (nuclear receptor subfamily 5 group A member 1) is located on Chromosome 9, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; 46,XY disorder of sex development | ATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATGCCCCTGGAGGAAGCCC... | ATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATGCCCCTGGAGGAAGCCC... |
Task1_train_13143 | This sequence change occurs on Chromosome 9, altering NR5A1 (nuclear receptor subfamily 5 group A member 1). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; Oligosynaptic infertility | ATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATGCCCCTGGAGGAAGCCC... | ATGAGCAGAAGGCAGGTGGGAGTATTCAAGACCCTGCCTTTTGCCTCATCCATTAGGTCGGACCAGAGAGGCGGGCAGTGTTGAGAAGGGGCTGGGGTGAGAAACCCACCCCATGACAGACACATGGTACATCCCCAGGCCTCAGCCATGACAGGCGCTCCACGGTGGAAGCCGTAGCCACCACCATCAATCCTCGACTCCCAGATGGCCCAGGCCCCAGTCCCGCGATGCCCCTAGGGCTCGGAGCACCCACCCCCACCTACCAGCCAGGGCAGGCAGTGCCCCCAGCCCATCCGGCCTCATGCCCCTGGAGGAAGCCC... |
Task1_train_13144 | A sequence alteration has been identified in NR5A1 (nuclear receptor subfamily 5 group A member 1) on Chromosome 9. Is it disease-inducing or harmless? | Pathogenic; 46,XY sex reversal 3 | GAACACCCAGCCTCAATGTCACTACTTCCAGGAAGCACTCCTGGATTCATGCAAACGGGCTCTACTGTCCTTGCCCCAGGTGCCCTGTCCTTGCCCACTCTTATCATGCTGAGTGGATCATGCCATGTGCTCCTGCGGGCTAAGTTCTGGGCTCAGGTGTCTAGCATAAGGCCTGGCAGGGAGATGGTGACCGGAAGGGGACCCTGGTCAGCCTTGTTCACCGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAA... | GAACACCCAGCCTCAATGTCACTACTTCCAGGAAGCACTCCTGGATTCATGCAAACGGGCTCTACTGTCCTTGCCCCAGGTGCCCTGTCCTTGCCCACTCTTATCATGCTGAGTGGATCATGCCATGTGCTCCTGCGGGCTAAGTTCTGGGCTCAGGTGTCTAGCATAAGGCCTGGCAGGGAGATGGTGACCGGAAGGGGACCCTGGTCAGCCTTGTTCACCGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAA... |
Task1_train_13145 | The gene NR5A1 (nuclear receptor subfamily 5 group A member 1) on Chromosome 9 contains a mutation. Based on this information, is the variant pathogenic or benign? Provide the disease if relevant. | Pathogenic; Disorder of sexual differentiation | TGTCACTACTTCCAGGAAGCACTCCTGGATTCATGCAAACGGGCTCTACTGTCCTTGCCCCAGGTGCCCTGTCCTTGCCCACTCTTATCATGCTGAGTGGATCATGCCATGTGCTCCTGCGGGCTAAGTTCTGGGCTCAGGTGTCTAGCATAAGGCCTGGCAGGGAGATGGTGACCGGAAGGGGACCCTGGTCAGCCTTGTTCACCGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTG... | TGTCACTACTTCCAGGAAGCACTCCTGGATTCATGCAAACGGGCTCTACTGTCCTTGCCCCAGGTGCCCTGTCCTTGCCCACTCTTATCATGCTGAGTGGATCATGCCATGTGCTCCTGCGGGCTAAGTTCTGGGCTCAGGTGTCTAGCATAAGGCCTGGCAGGGAGATGGTGACCGGAAGGGGACCCTGGTCAGCCTTGTTCACCGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTG... |
Task1_train_13146 | Here is a mutation in NR5A1 (nuclear receptor subfamily 5 group A member 1) on Chromosome 9. Determine whether it’s benign or pathogenic. If the latter, what disease does it cause? | Pathogenic; Disorder of sexual differentiation | TCCTGCGGGCTAAGTTCTGGGCTCAGGTGTCTAGCATAAGGCCTGGCAGGGAGATGGTGACCGGAAGGGGACCCTGGTCAGCCTTGTTCACCGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGT... | TCCTGCGGGCTAAGTTCTGGGCTCAGGTGTCTAGCATAAGGCCTGGCAGGGAGATGGTGACCGGAAGGGGACCCTGGTCAGCCTTGTTCACCGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGT... |
Task1_train_13147 | A variant was discovered on Chromosome 9, affecting NR5A1 (nuclear receptor subfamily 5 group A member 1). What is its functional impact — neutral or pathogenic? State the disease if pathogenic. | Pathogenic; not provided | GCCTTGTTCACCGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGC... | GCCTTGTTCACCGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGC... |
Task1_train_13148 | Gene NR5A1 (nuclear receptor subfamily 5 group A member 1) on Chromosome 9 is impacted by this variant. Evaluate whether it is clinically benign or pathogenic and name the disorder if relevant. | Pathogenic; Oligosynaptic infertility | CGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGCTCAGCAGGGAT... | CGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGCTCAGCAGGGAT... |
Task1_train_13149 | The following genetic variant occurs in NR5A1 (nuclear receptor subfamily 5 group A member 1) on Chromosome 9. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; 46,XY disorder of sex development | CGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGCTCAGCAGGGAT... | CGCTGGCCCCAGGGTCCAGCTGTTTGTTGACTGACTGCCTGACTGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGCTCAGCAGGGAT... |
Task1_train_13150 | Gene NR5A1 (nuclear receptor subfamily 5 group A member 1), found on Chromosome 9, is impacted by this variant. What is the biological outcome — benign or pathogenic? | Pathogenic; 46,XY sex reversal 3 | TGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGCTCAGCAGGGATGATGGCTGGGGGGCTGCCTGGCCAATCTTCCTGCCCCCTGGGG... | TGTTGAGCTCCTGCTTCAAAATGACTCAAGTATCCTTCACTGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGCTCAGCAGGGATGATGGCTGGGGGGCTGCCTGGCCAATCTTCCTGCCCCCTGGGG... |
Task1_train_13151 | Chromosome 9 houses a mutation in gene NR5A1 (nuclear receptor subfamily 5 group A member 1). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Premature ovarian failure 7 | TGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGCTCAGCAGGGATGATGGCTGGGGGGCTGCCTGGCCAATCTTCCTGCCCCCTGGGGTGGGCAGCGCTGTGCTGCTCGCAGGCTGCACGGGAGTTTC... | TGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGCTCAGCAGGGATGATGGCTGGGGGGCTGCCTGGCCAATCTTCCTGCCCCCTGGGGTGGGCAGCGCTGTGCTGCTCGCAGGCTGCACGGGAGTTTC... |
Task1_train_13152 | Gene NR5A1 (nuclear receptor subfamily 5 group A member 1) on Chromosome 9 is altered by this variant. Does this mutation result in a disease or is it benign? | Pathogenic; 46,XY sex reversal 3 | TGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGCTCAGCAGGGATGATGGCTGGGGGGCTGCCTGGCCAATCTTCCTGCCCCCTGGGGTGGGCAGCGCTGTGCTGCTCGCAGGCTGCACGGGAGTTTC... | TGGCTGCGAATGTGAAGCCAAGTTTAGAGCTGGCCAAGGCTCTATGCTGGGGGAGGGGACCTCTCTTGCCGACTAGAAGCTCCTCCGCCTGGCGAGGAATGTGTCATCAGCCAGACCCAACAGGTACATCTCTGCAGCTGGAGTGTGCCCCCCGCCCCTGCTCAGACAGGGCCCCACCCTGGGATCTGGGCGAGGGGAAAGAGCAGGAGAGAGGGGGTGGTGGTGCTCAGCAGGGATGATGGCTGGGGGGCTGCCTGGCCAATCTTCCTGCCCCCTGGGGTGGGCAGCGCTGTGCTGCTCGCAGGCTGCACGGGAGTTTC... |
Task1_train_13153 | A change on Chromosome 9 affects gene RPL35 (ribosomal protein L35). Identify whether the variant is neutral or disease-linked. Mention the disease if applicable. | Pathogenic; Diamond-Blackfan anemia 19 | GAGGATGTCACCAGTCTTGCCCTCCCAGCTCAAACCCTCCACTGGTTCCCATGGCCCATGCCCACAGCAGGCAACCAAGGCTGCCCCCACCTGGCCACAGCCGCCTCTCCAGGCTTCCTTGCACACAGCAGCCCTCAGGCTTTTTGCACGAGGTCCCCCTTTCCTGGACTGTCAAGGCCAGGTAGCCGGCTGCCCTCTGCTGCCTTCTGCAGCTCAGGGCTCTCTCTAGTCCGGCCAGATGCTGCGCCTCTTAGTTGGGCACCGTGACTCCATCCAGAGCAGCGACTTCTCACCCACGGTGAACTGCCTGGTGAGCCTAC... | GAGGATGTCACCAGTCTTGCCCTCCCAGCTCAAACCCTCCACTGGTTCCCATGGCCCATGCCCACAGCAGGCAACCAAGGCTGCCCCCACCTGGCCACAGCCGCCTCTCCAGGCTTCCTTGCACACAGCAGCCCTCAGGCTTTTTGCACGAGGTCCCCCTTTCCTGGACTGTCAAGGCCAGGTAGCCGGCTGCCCTCTGCTGCCTTCTGCAGCTCAGGGCTCTCTCTAGTCCGGCCAGATGCTGCGCCTCTTAGTTGGGCACCGTGACTCCATCCAGAGCAGCGACTTCTCACCCACGGTGAACTGCCTGGTGAGCCTAC... |
Task1_train_13154 | This alteration occurs within gene LMX1B (LIM homeobox transcription factor 1 beta) located on Chromosome 9. Is it associated with a disease or is it a benign variant? | Pathogenic; not provided | GCCGGCCCTCTCCGCGGACCAAGCGGCCCCGAGCAGGCGCCGCCGCCCGGGGGACTCCGACTCAGCCCCCGCGACCTACCTCGGCCGACAGTCGGGGGTTCCCAAGCGGCCACTCCCGGCCGGCGCCGTCCCCTGGCGGAGCCGCCGCGCTCCCTGCCGTCCGCGCAGTCTGGCCTCGCTCGGGGCCACTCCTCGTAGCGCTGGAGCTTTACAAAATATTAATAATAAAGAAGGCAGAGGAGAAAAAAGAAAGCCTTCGCTCCCCAACTCCCAAATCAATTTTTCAAGGGGGTGGAGCAGAGGGATTTGTTTCGAAGACG... | GCCGGCCCTCTCCGCGGACCAAGCGGCCCCGAGCAGGCGCCGCCGCCCGGGGGACTCCGACTCAGCCCCCGCGACCTACCTCGGCCGACAGTCGGGGGTTCCCAAGCGGCCACTCCCGGCCGGCGCCGTCCCCTGGCGGAGCCGCCGCGCTCCCTGCCGTCCGCGCAGTCTGGCCTCGCTCGGGGCCACTCCTCGTAGCGCTGGAGCTTTACAAAATATTAATAATAAAGAAGGCAGAGGAGAAAAAAGAAAGCCTTCGCTCCCCAACTCCCAAATCAATTTTTCAAGGGGGTGGAGCAGAGGGATTTGTTTCGAAGACG... |
Task1_train_13155 | This alteration occurs within gene LMX1B (LIM homeobox transcription factor 1 beta) located on Chromosome 9. Is it associated with a disease or is it a benign variant? | Pathogenic; Nail-patella syndrome | CCGGCCCTCTCCGCGGACCAAGCGGCCCCGAGCAGGCGCCGCCGCCCGGGGGACTCCGACTCAGCCCCCGCGACCTACCTCGGCCGACAGTCGGGGGTTCCCAAGCGGCCACTCCCGGCCGGCGCCGTCCCCTGGCGGAGCCGCCGCGCTCCCTGCCGTCCGCGCAGTCTGGCCTCGCTCGGGGCCACTCCTCGTAGCGCTGGAGCTTTACAAAATATTAATAATAAAGAAGGCAGAGGAGAAAAAAGAAAGCCTTCGCTCCCCAACTCCCAAATCAATTTTTCAAGGGGGTGGAGCAGAGGGATTTGTTTCGAAGACGA... | CCGGCCCTCTCCGCGGACCAAGCGGCCCCGAGCAGGCGCCGCCGCCCGGGGGACTCCGACTCAGCCCCCGCGACCTACCTCGGCCGACAGTCGGGGGTTCCCAAGCGGCCACTCCCGGCCGGCGCCGTCCCCTGGCGGAGCCGCCGCGCTCCCTGCCGTCCGCGCAGTCTGGCCTCGCTCGGGGCCACTCCTCGTAGCGCTGGAGCTTTACAAAATATTAATAATAAAGAAGGCAGAGGAGAAAAAAGAAAGCCTTCGCTCCCCAACTCCCAAATCAATTTTTCAAGGGGGTGGAGCAGAGGGATTTGTTTCGAAGACGA... |
Task1_train_13156 | The following genetic variant occurs in LMX1B (LIM homeobox transcription factor 1 beta) on Chromosome 9. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; not provided | CCCGCGACCTACCTCGGCCGACAGTCGGGGGTTCCCAAGCGGCCACTCCCGGCCGGCGCCGTCCCCTGGCGGAGCCGCCGCGCTCCCTGCCGTCCGCGCAGTCTGGCCTCGCTCGGGGCCACTCCTCGTAGCGCTGGAGCTTTACAAAATATTAATAATAAAGAAGGCAGAGGAGAAAAAAGAAAGCCTTCGCTCCCCAACTCCCAAATCAATTTTTCAAGGGGGTGGAGCAGAGGGATTTGTTTCGAAGACGATCAAAACTTCTGCGAGGGGCCCGCGGGGCGGCCGGGCCGGGGAGCCGGGGCCTGAGCTCGGGGCCA... | CCCGCGACCTACCTCGGCCGACAGTCGGGGGTTCCCAAGCGGCCACTCCCGGCCGGCGCCGTCCCCTGGCGGAGCCGCCGCGCTCCCTGCCGTCCGCGCAGTCTGGCCTCGCTCGGGGCCACTCCTCGTAGCGCTGGAGCTTTACAAAATATTAATAATAAAGAAGGCAGAGGAGAAAAAAGAAAGCCTTCGCTCCCCAACTCCCAAATCAATTTTTCAAGGGGGTGGAGCAGAGGGATTTGTTTCGAAGACGATCAAAACTTCTGCGAGGGGCCCGCGGGGCGGCCGGGCCGGGGAGCCGGGGCCTGAGCTCGGGGCCA... |
Task1_train_13157 | Given a variant located on Chromosome 9 and affecting LMX1B (LIM homeobox transcription factor 1 beta), assess whether it is benign or pathogenic. Indicate the associated disease if pathogenic. | Pathogenic; Nail-patella syndrome | CAGGCCTTTACTCACCTACTCTGTAAACACTCACGGAGGCCCCCTTGAGGATCAGATGGGGCCAGGTCCTGTCTCATGGAACCCTGGTAGAGGTGGTAGAGTTGGGCACCAACAGGGACATGCATTGTCATTCTGCTGTGATACCCGTGTACTGAGTTACATGCTCAGCATCCTCGAATCCTGACAACAGCCTTCAGGAAGGGCTTGACATCTCCATTTTACAGGAGTAAACTGAGGTGGGGGACGCTGAGGGGAGCATAGAGGAGGCTACCTCCCCCAGACTGGGGCATCAGAGAAGGCTTCCCAGAGGAGGTGGCATT... | CAGGCCTTTACTCACCTACTCTGTAAACACTCACGGAGGCCCCCTTGAGGATCAGATGGGGCCAGGTCCTGTCTCATGGAACCCTGGTAGAGGTGGTAGAGTTGGGCACCAACAGGGACATGCATTGTCATTCTGCTGTGATACCCGTGTACTGAGTTACATGCTCAGCATCCTCGAATCCTGACAACAGCCTTCAGGAAGGGCTTGACATCTCCATTTTACAGGAGTAAACTGAGGTGGGGGACGCTGAGGGGAGCATAGAGGAGGCTACCTCCCCCAGACTGGGGCATCAGAGAAGGCTTCCCAGAGGAGGTGGCATT... |
Task1_train_13158 | This sequence change occurs on Chromosome 9, altering LMX1B (LIM homeobox transcription factor 1 beta). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; not provided | TCCTGTCTCATGGAACCCTGGTAGAGGTGGTAGAGTTGGGCACCAACAGGGACATGCATTGTCATTCTGCTGTGATACCCGTGTACTGAGTTACATGCTCAGCATCCTCGAATCCTGACAACAGCCTTCAGGAAGGGCTTGACATCTCCATTTTACAGGAGTAAACTGAGGTGGGGGACGCTGAGGGGAGCATAGAGGAGGCTACCTCCCCCAGACTGGGGCATCAGAGAAGGCTTCCCAGAGGAGGTGGCATTGGAGTTGGGCATTGCAGGATGAGTAGGAGCCTGCTGGGTAGAATAGAGGTGGGTGGCAGGGGTTGC... | TCCTGTCTCATGGAACCCTGGTAGAGGTGGTAGAGTTGGGCACCAACAGGGACATGCATTGTCATTCTGCTGTGATACCCGTGTACTGAGTTACATGCTCAGCATCCTCGAATCCTGACAACAGCCTTCAGGAAGGGCTTGACATCTCCATTTTACAGGAGTAAACTGAGGTGGGGGACGCTGAGGGGAGCATAGAGGAGGCTACCTCCCCCAGACTGGGGCATCAGAGAAGGCTTCCCAGAGGAGGTGGCATTGGAGTTGGGCATTGCAGGATGAGTAGGAGCCTGCTGGGTAGAATAGAGGTGGGTGGCAGGGGTTGC... |
Task1_train_13159 | A mutation on Chromosome 9 affecting LMX1B (LIM homeobox transcription factor 1 beta) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Nail-patella syndrome | CAGATGCACACGCGCACTGACGTGTCCACCTGTGTGCACATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCC... | CAGATGCACACGCGCACTGACGTGTCCACCTGTGTGCACATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCC... |
Task1_train_13160 | The following genetic variant occurs in LMX1B (LIM homeobox transcription factor 1 beta) on Chromosome 9. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; Nail-patella-like renal disease | CAGATGCACACGCGCACTGACGTGTCCACCTGTGTGCACATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCC... | CAGATGCACACGCGCACTGACGTGTCCACCTGTGTGCACATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCC... |
Task1_train_13161 | This alteration in LMX1B (LIM homeobox transcription factor 1 beta) on Chromosome 9 may affect gene function. Does it lead to a disease or is it benign? | Pathogenic; Nail-patella syndrome | CAGATGCACACGCGCACTGACGTGTCCACCTGTGTGCACATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCC... | CAGATGCACACGCGCACTGACGTGTCCACCTGTGTGCACATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCC... |
Task1_train_13162 | A variant has been detected on Chromosome 9 in LMX1B (LIM homeobox transcription factor 1 beta). What is its effect — pathogenic or benign? If pathogenic, name the disease. | Pathogenic; Nail-patella syndrome | CATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACAT... | CATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACAT... |
Task1_train_13163 | Here is a genetic alteration in LMX1B (LIM homeobox transcription factor 1 beta) on Chromosome 9. Based on the data, is it a benign variant or a cause of disease? | Pathogenic; Nail-patella syndrome | CATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACAT... | CATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACAT... |
Task1_train_13164 | Chromosome 9 houses a mutation in gene LMX1B (LIM homeobox transcription factor 1 beta). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Nail-patella-like renal disease | CATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACAT... | CATGATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACAT... |
Task1_train_13165 | A variant has been detected on Chromosome 9 in LMX1B (LIM homeobox transcription factor 1 beta). What is its effect — pathogenic or benign? If pathogenic, name the disease. | Pathogenic; Nail-patella syndrome | GATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTA... | GATACGAACATGCATCCCCCCAGGCACACTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTA... |
Task1_train_13166 | This sequence variant lies in LMX1B (LIM homeobox transcription factor 1 beta) on Chromosome 9. Is it clinically significant, and what condition might it cause if any? | Pathogenic; Nail-patella-like renal disease | CTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACA... | CTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACA... |
Task1_train_13167 | A genomic change on Chromosome 9 affects LMX1B (LIM homeobox transcription factor 1 beta). Classify this variant as benign or pathogenic, and name the disease if relevant. | Pathogenic; Nail-patella syndrome | CTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACA... | CTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACA... |
Task1_train_13168 | Gene LMX1B (LIM homeobox transcription factor 1 beta) on Chromosome 9 is altered by this variant. Does this mutation result in a disease or is it benign? | Pathogenic; Nail-patella syndrome | CTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACA... | CTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACA... |
Task1_train_13169 | Gene LMX1B (LIM homeobox transcription factor 1 beta), found on Chromosome 9, is impacted by this variant. What is the biological outcome — benign or pathogenic? | Pathogenic; Inherited focal segmental glomerulosclerosis | CTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACA... | CTACCCCTGAGACCTACGCATCCATACATATAAACATATGTGTGATCACATGTGTGCACACAAGCACATAAAATGCATGCAGGAATACCCCTACCCTGAGTATGGATACATGTACATGTATGTGGAGATATGTGTTCACATACCCGGGAATTCAAAAGCCACACCCAGGTCCACACACACAAGTGTACACACTTAAGCATACATACACATACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACA... |
Task1_train_13170 | Gene LMX1B (LIM homeobox transcription factor 1 beta) on Chromosome 9 is impacted by this variant. Evaluate whether it is clinically benign or pathogenic and name the disorder if relevant. | Pathogenic; Nail-patella syndrome | TACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACACACCTCTTGTTCTCTGGCCCACCCCCCTTACCCTCTCTGCCTTGATGGCCCCCCACCAACCCGCAGCCCAGCTCCACAGGGGTCTTCACCAGCACCCAGTCCACAGGCTGGGGATGCCTGAGAGGCAGGGAGATGATGTGCCTTCCCCTTCTCAGCCCCCTGGAGCCTTCAGCAGTGAGAAGCAAACAGCCTCGAGCCAGCCTCTGTTT... | TACACACATGACACAGCACACTTGTGCACTAAACACCGGTCCACATGGCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACACACCTCTTGTTCTCTGGCCCACCCCCCTTACCCTCTCTGCCTTGATGGCCCCCCACCAACCCGCAGCCCAGCTCCACAGGGGTCTTCACCAGCACCCAGTCCACAGGCTGGGGATGCCTGAGAGGCAGGGAGATGATGTGCCTTCCCCTTCTCAGCCCCCTGGAGCCTTCAGCAGTGAGAAGCAAACAGCCTCGAGCCAGCCTCTGTTT... |
Task1_train_13171 | A sequence alteration has been identified in LMX1B (LIM homeobox transcription factor 1 beta) on Chromosome 9. Is it disease-inducing or harmless? | Pathogenic; Nail-patella syndrome | GCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACACACCTCTTGTTCTCTGGCCCACCCCCCTTACCCTCTCTGCCTTGATGGCCCCCCACCAACCCGCAGCCCAGCTCCACAGGGGTCTTCACCAGCACCCAGTCCACAGGCTGGGGATGCCTGAGAGGCAGGGAGATGATGTGCCTTCCCCTTCTCAGCCCCCTGGAGCCTTCAGCAGTGAGAAGCAAACAGCCTCGAGCCAGCCTCTGTTTCCCAGCCGAAGGGAGGGGGCTGGGCCCTCTGTGCTGGAGGGAAAGAC... | GCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACACACCTCTTGTTCTCTGGCCCACCCCCCTTACCCTCTCTGCCTTGATGGCCCCCCACCAACCCGCAGCCCAGCTCCACAGGGGTCTTCACCAGCACCCAGTCCACAGGCTGGGGATGCCTGAGAGGCAGGGAGATGATGTGCCTTCCCCTTCTCAGCCCCCTGGAGCCTTCAGCAGTGAGAAGCAAACAGCCTCGAGCCAGCCTCTGTTTCCCAGCCGAAGGGAGGGGGCTGGGCCCTCTGTGCTGGAGGGAAAGAC... |
Task1_train_13172 | With a mutation on Chromosome 9 in gene LMX1B (LIM homeobox transcription factor 1 beta), classify this variant as benign or pathogenic. Include the disease if it's pathogenic. | Pathogenic; Nail-patella syndrome | GCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACACACCTCTTGTTCTCTGGCCCACCCCCCTTACCCTCTCTGCCTTGATGGCCCCCCACCAACCCGCAGCCCAGCTCCACAGGGGTCTTCACCAGCACCCAGTCCACAGGCTGGGGATGCCTGAGAGGCAGGGAGATGATGTGCCTTCCCCTTCTCAGCCCCCTGGAGCCTTCAGCAGTGAGAAGCAAACAGCCTCGAGCCAGCCTCTGTTTCCCAGCCGAAGGGAGGGGGCTGGGCCCTCTGTGCTGGAGGGAAAGAC... | GCTGCACATATATGTTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACACACCTCTTGTTCTCTGGCCCACCCCCCTTACCCTCTCTGCCTTGATGGCCCCCCACCAACCCGCAGCCCAGCTCCACAGGGGTCTTCACCAGCACCCAGTCCACAGGCTGGGGATGCCTGAGAGGCAGGGAGATGATGTGCCTTCCCCTTCTCAGCCCCCTGGAGCCTTCAGCAGTGAGAAGCAAACAGCCTCGAGCCAGCCTCTGTTTCCCAGCCGAAGGGAGGGGGCTGGGCCCTCTGTGCTGGAGGGAAAGAC... |
Task1_train_13173 | Gene LMX1B (LIM homeobox transcription factor 1 beta), found on Chromosome 9, is impacted by this variant. What is the biological outcome — benign or pathogenic? | Pathogenic; Nail-patella syndrome | TTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACACACCTCTTGTTCTCTGGCCCACCCCCCTTACCCTCTCTGCCTTGATGGCCCCCCACCAACCCGCAGCCCAGCTCCACAGGGGTCTTCACCAGCACCCAGTCCACAGGCTGGGGATGCCTGAGAGGCAGGGAGATGATGTGCCTTCCCCTTCTCAGCCCCCTGGAGCCTTCAGCAGTGAGAAGCAAACAGCCTCGAGCCAGCCTCTGTTTCCCAGCCGAAGGGAGGGGGCTGGGCCCTCTGTGCTGGAGGGAAAGACCCCATTTCCCAGGG... | TTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACACACCTCTTGTTCTCTGGCCCACCCCCCTTACCCTCTCTGCCTTGATGGCCCCCCACCAACCCGCAGCCCAGCTCCACAGGGGTCTTCACCAGCACCCAGTCCACAGGCTGGGGATGCCTGAGAGGCAGGGAGATGATGTGCCTTCCCCTTCTCAGCCCCCTGGAGCCTTCAGCAGTGAGAAGCAAACAGCCTCGAGCCAGCCTCTGTTTCCCAGCCGAAGGGAGGGGGCTGGGCCCTCTGTGCTGGAGGGAAAGACCCCATTTCCCAGGG... |
Task1_train_13174 | This mutation occurs in LMX1B (LIM homeobox transcription factor 1 beta) on Chromosome 9. Does this change lead to a known medical condition, or is it benign? | Pathogenic; Nail-patella-like renal disease | TTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACACACCTCTTGTTCTCTGGCCCACCCCCCTTACCCTCTCTGCCTTGATGGCCCCCCACCAACCCGCAGCCCAGCTCCACAGGGGTCTTCACCAGCACCCAGTCCACAGGCTGGGGATGCCTGAGAGGCAGGGAGATGATGTGCCTTCCCCTTCTCAGCCCCCTGGAGCCTTCAGCAGTGAGAAGCAAACAGCCTCGAGCCAGCCTCTGTTTCCCAGCCGAAGGGAGGGGGCTGGGCCCTCTGTGCTGGAGGGAAAGACCCCATTTCCCAGGG... | TTTGTCCACATGCTCACATGTACTGTGGATTGTGCTTGTGTGCACACACACACCTCTTGTTCTCTGGCCCACCCCCCTTACCCTCTCTGCCTTGATGGCCCCCCACCAACCCGCAGCCCAGCTCCACAGGGGTCTTCACCAGCACCCAGTCCACAGGCTGGGGATGCCTGAGAGGCAGGGAGATGATGTGCCTTCCCCTTCTCAGCCCCCTGGAGCCTTCAGCAGTGAGAAGCAAACAGCCTCGAGCCAGCCTCTGTTTCCCAGCCGAAGGGAGGGGGCTGGGCCCTCTGTGCTGGAGGGAAAGACCCCATTTCCCAGGG... |
Task1_train_13175 | This sequence variant lies in LRSAM1 (leucine rich repeat and sterile alpha motif containing 1) on Chromosome 9. Is it clinically significant, and what condition might it cause if any? | Pathogenic; Charcot-Marie-Tooth disease axonal type 2P | CCCACTTAACAAGCGCTGCGGCCATCCCTGCAGAGAGAGACTTCACTCCCATTCTGCAGATGGGAAATGAGGCTCAGAGAAGAGAAGAAGAGAGTGTGTGGCAAGGAGAGCACTTCCCTCAGATCTGAGAGCAGAGGCTCCCCCACCCTCCAGCTCACTCACCATGGGGATGGGCAGGGCCACAATGAGCCCCCAGGGGTTAGGGTCAGCGGAGATGACCCTGGCTCAGTCTGTCTGTCTGGTCCCCACAGAGCTGAAACCACCAATGGGTGAGGTCGTCACCCCTACGGCCCCCCAGGAGCCTCCTGAGTCTGTGAGGC... | CCCACTTAACAAGCGCTGCGGCCATCCCTGCAGAGAGAGACTTCACTCCCATTCTGCAGATGGGAAATGAGGCTCAGAGAAGAGAAGAAGAGAGTGTGTGGCAAGGAGAGCACTTCCCTCAGATCTGAGAGCAGAGGCTCCCCCACCCTCCAGCTCACTCACCATGGGGATGGGCAGGGCCACAATGAGCCCCCAGGGGTTAGGGTCAGCGGAGATGACCCTGGCTCAGTCTGTCTGTCTGGTCCCCACAGAGCTGAAACCACCAATGGGTGAGGTCGTCACCCCTACGGCCCCCCAGGAGCCTCCTGAGTCTGTGAGGC... |
Task1_train_13176 | A variant has been detected on Chromosome 9 in LRSAM1 (leucine rich repeat and sterile alpha motif containing 1). What is its effect — pathogenic or benign? If pathogenic, name the disease. | Pathogenic; Charcot-Marie-Tooth disease axonal type 2P | CCACTTAACAAGCGCTGCGGCCATCCCTGCAGAGAGAGACTTCACTCCCATTCTGCAGATGGGAAATGAGGCTCAGAGAAGAGAAGAAGAGAGTGTGTGGCAAGGAGAGCACTTCCCTCAGATCTGAGAGCAGAGGCTCCCCCACCCTCCAGCTCACTCACCATGGGGATGGGCAGGGCCACAATGAGCCCCCAGGGGTTAGGGTCAGCGGAGATGACCCTGGCTCAGTCTGTCTGTCTGGTCCCCACAGAGCTGAAACCACCAATGGGTGAGGTCGTCACCCCTACGGCCCCCCAGGAGCCTCCTGAGTCTGTGAGGCC... | CCACTTAACAAGCGCTGCGGCCATCCCTGCAGAGAGAGACTTCACTCCCATTCTGCAGATGGGAAATGAGGCTCAGAGAAGAGAAGAAGAGAGTGTGTGGCAAGGAGAGCACTTCCCTCAGATCTGAGAGCAGAGGCTCCCCCACCCTCCAGCTCACTCACCATGGGGATGGGCAGGGCCACAATGAGCCCCCAGGGGTTAGGGTCAGCGGAGATGACCCTGGCTCAGTCTGTCTGTCTGGTCCCCACAGAGCTGAAACCACCAATGGGTGAGGTCGTCACCCCTACGGCCCCCCAGGAGCCTCCTGAGTCTGTGAGGCC... |
Task1_train_13177 | This variant affects the gene LOC130002651, STXBP1 (ATAC-STARR-seq lymphoblastoid silent region 20307| syntaxin binding protein 1) found on Chromosome 9. What is the clinical effect of this variant — benign or pathogenic? State the disease if applicable. | Pathogenic; Early infantile epileptic encephalopathy with suppression bursts | CTGATATGTGCCAGCTGGCGAAGGAGGAAGCATGTGGCATTACCAGTGCATCCTAGGTCTCCCCATGTTTACACACTATCTCCTCCTCCAAATACACACAGGGGCTATCAATATGTTTCCTGGGCAAAAGGCAAGGCCCAGACATAGAGAGTTGACACATTAACGCCTCCTCTCTCTCTGAACCCATCTGAAGGTTCTGTTGGGGGTAGATTGGGGTGGTGGTGAGAAGATGGTCAAATCTGCTTGACTTGGGGCTGGCGACTGAAGTAGGACATGTAGCCTCTTGTCCTGGCTCAGCCACCACTGGCTTCTGTGACTTT... | CTGATATGTGCCAGCTGGCGAAGGAGGAAGCATGTGGCATTACCAGTGCATCCTAGGTCTCCCCATGTTTACACACTATCTCCTCCTCCAAATACACACAGGGGCTATCAATATGTTTCCTGGGCAAAAGGCAAGGCCCAGACATAGAGAGTTGACACATTAACGCCTCCTCTCTCTCTGAACCCATCTGAAGGTTCTGTTGGGGGTAGATTGGGGTGGTGGTGAGAAGATGGTCAAATCTGCTTGACTTGGGGCTGGCGACTGAAGTAGGACATGTAGCCTCTTGTCCTGGCTCAGCCACCACTGGCTTCTGTGACTTT... |
Task1_train_13178 | This genomic variant is located on Chromosome 9, within the LOC130002651, STXBP1 (ATAC-STARR-seq lymphoblastoid silent region 20307| syntaxin binding protein 1) gene. Can you determine its pathogenicity and name any linked disease? | Pathogenic; Developmental and epileptic encephalopathy, 4 | CTGATATGTGCCAGCTGGCGAAGGAGGAAGCATGTGGCATTACCAGTGCATCCTAGGTCTCCCCATGTTTACACACTATCTCCTCCTCCAAATACACACAGGGGCTATCAATATGTTTCCTGGGCAAAAGGCAAGGCCCAGACATAGAGAGTTGACACATTAACGCCTCCTCTCTCTCTGAACCCATCTGAAGGTTCTGTTGGGGGTAGATTGGGGTGGTGGTGAGAAGATGGTCAAATCTGCTTGACTTGGGGCTGGCGACTGAAGTAGGACATGTAGCCTCTTGTCCTGGCTCAGCCACCACTGGCTTCTGTGACTTT... | CTGATATGTGCCAGCTGGCGAAGGAGGAAGCATGTGGCATTACCAGTGCATCCTAGGTCTCCCCATGTTTACACACTATCTCCTCCTCCAAATACACACAGGGGCTATCAATATGTTTCCTGGGCAAAAGGCAAGGCCCAGACATAGAGAGTTGACACATTAACGCCTCCTCTCTCTCTGAACCCATCTGAAGGTTCTGTTGGGGGTAGATTGGGGTGGTGGTGAGAAGATGGTCAAATCTGCTTGACTTGGGGCTGGCGACTGAAGTAGGACATGTAGCCTCTTGTCCTGGCTCAGCCACCACTGGCTTCTGTGACTTT... |
Task1_train_13179 | This variant affects the gene STXBP1 (syntaxin binding protein 1) found on Chromosome 9. What is the clinical effect of this variant — benign or pathogenic? State the disease if applicable. | Pathogenic; not provided | CTTATTGCAACCTCCGATTCCCTGGTTCAAGTGACTCTCCTGCCTCACCCTCCCAAGTGGCTGGGATTACAGGCATGCACCACCATGCCCAGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCGATCTCCTGACCTCGTGATTCACCCACCTTGGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACCGTGCCTGGCCTGATTGTTTTTTAAGCACATGAGTAATACATTGAATTTTTTCTTTTCTTTTTTTTTTGAGATGGAGTCTGGCTCTGGGTCTGTCACCCAGGCT... | CTTATTGCAACCTCCGATTCCCTGGTTCAAGTGACTCTCCTGCCTCACCCTCCCAAGTGGCTGGGATTACAGGCATGCACCACCATGCCCAGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCGATCTCCTGACCTCGTGATTCACCCACCTTGGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACCGTGCCTGGCCTGATTGTTTTTTAAGCACATGAGTAATACATTGAATTTTTTCTTTTCTTTTTTTTTTGAGATGGAGTCTGGCTCTGGGTCTGTCACCCAGGCT... |
Task1_train_13180 | A genetic alteration is present in STXBP1 (syntaxin binding protein 1) on Chromosome 9. Is this variant benign or disease-causing, and if the latter, which condition is involved? | Pathogenic; Developmental and epileptic encephalopathy, 4 | AATCAGAAGGGGATGGAGTTGGAGGAAAGTTGTAGGCAGGAATGAGGGCTTTTGCTGTGTCCAGAGAGTACAGAATGCTCCTGGATTGGAGAAAGGTGATCTGCTCTGCCTCACATTTCATATGGTCTTGGTTAAGAATTCTGTTTGTCATAAAGCTTATCTTAAAGACCACCTGGTCAGGCAGTTAGCAGTGGAACTCTTTTGTTCAAACAAAATATTACCTGGAACCCGTTAGATAAAGCAGAGGAAGGTATAATTCTGCTGGCTCTGGGAGAGGAAGAAGAGGCCCTCTTGCCCCTTTGTGGCCATAAAGCATCTCC... | AATCAGAAGGGGATGGAGTTGGAGGAAAGTTGTAGGCAGGAATGAGGGCTTTTGCTGTGTCCAGAGAGTACAGAATGCTCCTGGATTGGAGAAAGGTGATCTGCTCTGCCTCACATTTCATATGGTCTTGGTTAAGAATTCTGTTTGTCATAAAGCTTATCTTAAAGACCACCTGGTCAGGCAGTTAGCAGTGGAACTCTTTTGTTCAAACAAAATATTACCTGGAACCCGTTAGATAAAGCAGAGGAAGGTATAATTCTGCTGGCTCTGGGAGAGGAAGAAGAGGCCCTCTTGCCCCTTTGTGGCCATAAAGCATCTCC... |
Task1_train_13181 | Here is a mutation in STXBP1 (syntaxin binding protein 1) on Chromosome 9. Determine whether it’s benign or pathogenic. If the latter, what disease does it cause? | Pathogenic; Early infantile epileptic encephalopathy with suppression bursts | ATCTGCTCGCCTTGGCTTCCCAAAGTGCTGGGATTACAGACGTGAGCTACTGTGCCCTGCCCCAAGTCAGTTTTAAGACTAGGCTTGCCCCTATTTTGAGTTTATGATGTTATTTTCTTCATTGAATTTTTGAAACTATTTTTTTCGTCTATCAAAGCAAAAACAGACAAAAAACACAAAAGTAAAGGAGAAAAACACTAAATGGAGCTAACAAGGATCTAAGAAAAGAGCAGTGACCTCCTGTCCTCCTATCTCCCATCCTCGGGGTCTATTACCCCAGAGGCAGCCACCTCGCCCTTCATTCTGGACATCTTTTTTAT... | ATCTGCTCGCCTTGGCTTCCCAAAGTGCTGGGATTACAGACGTGAGCTACTGTGCCCTGCCCCAAGTCAGTTTTAAGACTAGGCTTGCCCCTATTTTGAGTTTATGATGTTATTTTCTTCATTGAATTTTTGAAACTATTTTTTTCGTCTATCAAAGCAAAAACAGACAAAAAACACAAAAGTAAAGGAGAAAAACACTAAATGGAGCTAACAAGGATCTAAGAAAAGAGCAGTGACCTCCTGTCCTCCTATCTCCCATCCTCGGGGTCTATTACCCCAGAGGCAGCCACCTCGCCCTTCATTCTGGACATCTTTTTTAT... |
Task1_train_13182 | Gene STXBP1 (syntaxin binding protein 1) on Chromosome 9 is impacted by this variant. Evaluate whether it is clinically benign or pathogenic and name the disorder if relevant. | Pathogenic; Developmental and epileptic encephalopathy, 4 | GTAGCTGGAATTATAGGCACATTCCAACATGCCTGGCTAATTTTTGTAGTTTTTTAGTAGAGATGAGGTTTCACCATGTTGGCCAGGCTGGTCTTGAACTCCTGACATCAAGTGATGTGCCCACCTCAGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACCATGCCCAGCCCAGATTTCAGATTCTAACATCTTGGGCATGTTGAGACCATGGAATTCACTCCCAAGGAACGTGGTAACCTTAAGGAATGAGTGAATGATTCCCCCCGGTCCCCCACTGTAGATATTTATCTGCAACAGTCTGAAGGTAGCCTGTC... | GTAGCTGGAATTATAGGCACATTCCAACATGCCTGGCTAATTTTTGTAGTTTTTTAGTAGAGATGAGGTTTCACCATGTTGGCCAGGCTGGTCTTGAACTCCTGACATCAAGTGATGTGCCCACCTCAGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACCATGCCCAGCCCAGATTTCAGATTCTAACATCTTGGGCATGTTGAGACCATGGAATTCACTCCCAAGGAACGTGGTAACCTTAAGGAATGAGTGAATGATTCCCCCCGGTCCCCCACTGTAGATATTTATCTGCAACAGTCTGAAGGTAGCCTGTC... |
Task1_train_13183 | Gene STXBP1 (syntaxin binding protein 1) on Chromosome 9 is impacted by this variant. Evaluate whether it is clinically benign or pathogenic and name the disorder if relevant. | Pathogenic; Early infantile epileptic encephalopathy with suppression bursts | GTTGGCCAGGCTGGTCTCGAACTCCTGACCTCAAGTGATCTACCTGTCTTGGTCTCCCAAAGTGCTGGGATTACAAGCATGAGCCACCACTCTCAGCCTTTTTTGTTTTTTTGGGTTGTTGTTGTTGTTTTTTGTTTGTTTGTTTTTGTTTTTGTTTTTTTTTGTTTTTTTTTTGAGACAGGTCTCTCTCCATCACCCAGGCTGGAGTGCAGTGTTGTGATCACAGTTCACTACAGCCCCGACCTCCGGGGCTTAAGTGATCCTCCCACCTCAGCCTCCCAAACAGCTGGGACTACAGGCACATGCCACCATGCCCAGCT... | GTTGGCCAGGCTGGTCTCGAACTCCTGACCTCAAGTGATCTACCTGTCTTGGTCTCCCAAAGTGCTGGGATTACAAGCATGAGCCACCACTCTCAGCCTTTTTTGTTTTTTTGGGTTGTTGTTGTTGTTTTTTGTTTGTTTGTTTTTGTTTTTGTTTTTTTTTGTTTTTTTTTTGAGACAGGTCTCTCTCCATCACCCAGGCTGGAGTGCAGTGTTGTGATCACAGTTCACTACAGCCCCGACCTCCGGGGCTTAAGTGATCCTCCCACCTCAGCCTCCCAAACAGCTGGGACTACAGGCACATGCCACCATGCCCAGCT... |
Task1_train_13184 | A mutation in STXBP1 (syntaxin binding protein 1), located on Chromosome 9, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; Inborn genetic diseases | GTGGGACCTACTAAAGAGTTGAGGAGGGAAGGTACCATGCTCTGAATTGCCAAATGACAGGTTAGAAGTGGATGTTTACTGAATGGAAATAGTATTCCATAGGGCCTGCCCCCTGCCCTCATCTTACTCTCCAGTTGTTTCTGACTTTGCTTCAGCCTTGTGCCTTTCTTTGTGTGCATTTCATCCTTGCTCTCAGTGTTCACTCCTGTCGGCCGACTCCTTGAATAACCACTAAGTAGCCAATCAGAAACGAGCTTGGAAGGAGAGCGAGGGTGGGGAGCAGAAGCATCCCATCTGCTGCGAAGGAGACTGTTTTTTAC... | GTGGGACCTACTAAAGAGTTGAGGAGGGAAGGTACCATGCTCTGAATTGCCAAATGACAGGTTAGAAGTGGATGTTTACTGAATGGAAATAGTATTCCATAGGGCCTGCCCCCTGCCCTCATCTTACTCTCCAGTTGTTTCTGACTTTGCTTCAGCCTTGTGCCTTTCTTTGTGTGCATTTCATCCTTGCTCTCAGTGTTCACTCCTGTCGGCCGACTCCTTGAATAACCACTAAGTAGCCAATCAGAAACGAGCTTGGAAGGAGAGCGAGGGTGGGGAGCAGAAGCATCCCATCTGCTGCGAAGGAGACTGTTTTTTAC... |
Task1_train_13185 | This alteration occurs within gene STXBP1 (syntaxin binding protein 1) located on Chromosome 9. Is it associated with a disease or is it a benign variant? | Pathogenic; Developmental and epileptic encephalopathy, 4 | AGGTACCATGCTCTGAATTGCCAAATGACAGGTTAGAAGTGGATGTTTACTGAATGGAAATAGTATTCCATAGGGCCTGCCCCCTGCCCTCATCTTACTCTCCAGTTGTTTCTGACTTTGCTTCAGCCTTGTGCCTTTCTTTGTGTGCATTTCATCCTTGCTCTCAGTGTTCACTCCTGTCGGCCGACTCCTTGAATAACCACTAAGTAGCCAATCAGAAACGAGCTTGGAAGGAGAGCGAGGGTGGGGAGCAGAAGCATCCCATCTGCTGCGAAGGAGACTGTTTTTTACGTGGAGATAACCTCAGCTTGTCATGTGCT... | AGGTACCATGCTCTGAATTGCCAAATGACAGGTTAGAAGTGGATGTTTACTGAATGGAAATAGTATTCCATAGGGCCTGCCCCCTGCCCTCATCTTACTCTCCAGTTGTTTCTGACTTTGCTTCAGCCTTGTGCCTTTCTTTGTGTGCATTTCATCCTTGCTCTCAGTGTTCACTCCTGTCGGCCGACTCCTTGAATAACCACTAAGTAGCCAATCAGAAACGAGCTTGGAAGGAGAGCGAGGGTGGGGAGCAGAAGCATCCCATCTGCTGCGAAGGAGACTGTTTTTTACGTGGAGATAACCTCAGCTTGTCATGTGCT... |
Task1_train_13186 | Consider a variant on Chromosome 9 in gene STXBP1 (syntaxin binding protein 1). Determine its clinical classification and disease relevance. | Pathogenic; Early infantile epileptic encephalopathy with suppression bursts | AGGTACCATGCTCTGAATTGCCAAATGACAGGTTAGAAGTGGATGTTTACTGAATGGAAATAGTATTCCATAGGGCCTGCCCCCTGCCCTCATCTTACTCTCCAGTTGTTTCTGACTTTGCTTCAGCCTTGTGCCTTTCTTTGTGTGCATTTCATCCTTGCTCTCAGTGTTCACTCCTGTCGGCCGACTCCTTGAATAACCACTAAGTAGCCAATCAGAAACGAGCTTGGAAGGAGAGCGAGGGTGGGGAGCAGAAGCATCCCATCTGCTGCGAAGGAGACTGTTTTTTACGTGGAGATAACCTCAGCTTGTCATGTGCT... | AGGTACCATGCTCTGAATTGCCAAATGACAGGTTAGAAGTGGATGTTTACTGAATGGAAATAGTATTCCATAGGGCCTGCCCCCTGCCCTCATCTTACTCTCCAGTTGTTTCTGACTTTGCTTCAGCCTTGTGCCTTTCTTTGTGTGCATTTCATCCTTGCTCTCAGTGTTCACTCCTGTCGGCCGACTCCTTGAATAACCACTAAGTAGCCAATCAGAAACGAGCTTGGAAGGAGAGCGAGGGTGGGGAGCAGAAGCATCCCATCTGCTGCGAAGGAGACTGTTTTTTACGTGGAGATAACCTCAGCTTGTCATGTGCT... |
Task1_train_13187 | Here is a variant affecting STXBP1 (syntaxin binding protein 1) on Chromosome 9. Please identify whether it is a benign mutation or associated with a disorder. | Pathogenic; Neurodevelopmental delay | AGGTACCATGCTCTGAATTGCCAAATGACAGGTTAGAAGTGGATGTTTACTGAATGGAAATAGTATTCCATAGGGCCTGCCCCCTGCCCTCATCTTACTCTCCAGTTGTTTCTGACTTTGCTTCAGCCTTGTGCCTTTCTTTGTGTGCATTTCATCCTTGCTCTCAGTGTTCACTCCTGTCGGCCGACTCCTTGAATAACCACTAAGTAGCCAATCAGAAACGAGCTTGGAAGGAGAGCGAGGGTGGGGAGCAGAAGCATCCCATCTGCTGCGAAGGAGACTGTTTTTTACGTGGAGATAACCTCAGCTTGTCATGTGCT... | AGGTACCATGCTCTGAATTGCCAAATGACAGGTTAGAAGTGGATGTTTACTGAATGGAAATAGTATTCCATAGGGCCTGCCCCCTGCCCTCATCTTACTCTCCAGTTGTTTCTGACTTTGCTTCAGCCTTGTGCCTTTCTTTGTGTGCATTTCATCCTTGCTCTCAGTGTTCACTCCTGTCGGCCGACTCCTTGAATAACCACTAAGTAGCCAATCAGAAACGAGCTTGGAAGGAGAGCGAGGGTGGGGAGCAGAAGCATCCCATCTGCTGCGAAGGAGACTGTTTTTTACGTGGAGATAACCTCAGCTTGTCATGTGCT... |
Task1_train_13188 | Consider a variant on Chromosome 9 in gene STXBP1 (syntaxin binding protein 1). Determine its clinical classification and disease relevance. | Pathogenic; Early infantile epileptic encephalopathy with suppression bursts | CTCTGAATTGCCAAATGACAGGTTAGAAGTGGATGTTTACTGAATGGAAATAGTATTCCATAGGGCCTGCCCCCTGCCCTCATCTTACTCTCCAGTTGTTTCTGACTTTGCTTCAGCCTTGTGCCTTTCTTTGTGTGCATTTCATCCTTGCTCTCAGTGTTCACTCCTGTCGGCCGACTCCTTGAATAACCACTAAGTAGCCAATCAGAAACGAGCTTGGAAGGAGAGCGAGGGTGGGGAGCAGAAGCATCCCATCTGCTGCGAAGGAGACTGTTTTTTACGTGGAGATAACCTCAGCTTGTCATGTGCTGAGAGAGCAG... | CTCTGAATTGCCAAATGACAGGTTAGAAGTGGATGTTTACTGAATGGAAATAGTATTCCATAGGGCCTGCCCCCTGCCCTCATCTTACTCTCCAGTTGTTTCTGACTTTGCTTCAGCCTTGTGCCTTTCTTTGTGTGCATTTCATCCTTGCTCTCAGTGTTCACTCCTGTCGGCCGACTCCTTGAATAACCACTAAGTAGCCAATCAGAAACGAGCTTGGAAGGAGAGCGAGGGTGGGGAGCAGAAGCATCCCATCTGCTGCGAAGGAGACTGTTTTTTACGTGGAGATAACCTCAGCTTGTCATGTGCTGAGAGAGCAG... |
Task1_train_13189 | A sequence alteration has been identified in STXBP1 (syntaxin binding protein 1) on Chromosome 9. Is it disease-inducing or harmless? | Pathogenic; Early infantile epileptic encephalopathy with suppression bursts | ATGACAGGTTTGGGATTATGTCCTTCGGTGGTTATCACTGGAAACCTATGGGGGATTTGGACGGGGATGACCACAGTTCTCTGGGAGAGTGAAGGCTGGAGTATAAGCAGGAGTCAGGGCAAGGAAAAACCAGAAGGGGTGGCTAACCAGGAGGCCACTGCAGGAGGAACAAAGGGCCTGGTCTTGGAGTGATGGGAACGGGGTGGACAGGTAAGGACAGAATCTGAGAGCGTGCAGAGGTGGATTCGGAACTGCCAGCAGGTTAGTAGTAGGGCAGGAAGGGCTTAGGCTGCCAAGGCATTGTGCCGTGGTAACCAAGA... | ATGACAGGTTTGGGATTATGTCCTTCGGTGGTTATCACTGGAAACCTATGGGGGATTTGGACGGGGATGACCACAGTTCTCTGGGAGAGTGAAGGCTGGAGTATAAGCAGGAGTCAGGGCAAGGAAAAACCAGAAGGGGTGGCTAACCAGGAGGCCACTGCAGGAGGAACAAAGGGCCTGGTCTTGGAGTGATGGGAACGGGGTGGACAGGTAAGGACAGAATCTGAGAGCGTGCAGAGGTGGATTCGGAACTGCCAGCAGGTTAGTAGTAGGGCAGGAAGGGCTTAGGCTGCCAAGGCATTGTGCCGTGGTAACCAAGA... |
Task1_train_13190 | Mutation context: Chromosome 9, Gene STXBP1 (syntaxin binding protein 1). Determine if this variant is likely to be benign or pathogenic. Mention the disease if applicable. | Pathogenic; Developmental and epileptic encephalopathy, 4 | ATGACAGGTTTGGGATTATGTCCTTCGGTGGTTATCACTGGAAACCTATGGGGGATTTGGACGGGGATGACCACAGTTCTCTGGGAGAGTGAAGGCTGGAGTATAAGCAGGAGTCAGGGCAAGGAAAAACCAGAAGGGGTGGCTAACCAGGAGGCCACTGCAGGAGGAACAAAGGGCCTGGTCTTGGAGTGATGGGAACGGGGTGGACAGGTAAGGACAGAATCTGAGAGCGTGCAGAGGTGGATTCGGAACTGCCAGCAGGTTAGTAGTAGGGCAGGAAGGGCTTAGGCTGCCAAGGCATTGTGCCGTGGTAACCAAGA... | ATGACAGGTTTGGGATTATGTCCTTCGGTGGTTATCACTGGAAACCTATGGGGGATTTGGACGGGGATGACCACAGTTCTCTGGGAGAGTGAAGGCTGGAGTATAAGCAGGAGTCAGGGCAAGGAAAAACCAGAAGGGGTGGCTAACCAGGAGGCCACTGCAGGAGGAACAAAGGGCCTGGTCTTGGAGTGATGGGAACGGGGTGGACAGGTAAGGACAGAATCTGAGAGCGTGCAGAGGTGGATTCGGAACTGCCAGCAGGTTAGTAGTAGGGCAGGAAGGGCTTAGGCTGCCAAGGCATTGTGCCGTGGTAACCAAGA... |
Task1_train_13191 | The gene STXBP1 (syntaxin binding protein 1), on Chromosome 9, contains a mutation. Does this mutation cause a disorder, or is it a benign change? | Pathogenic; Developmental and epileptic encephalopathy, 4 | GGTTATCACTGGAAACCTATGGGGGATTTGGACGGGGATGACCACAGTTCTCTGGGAGAGTGAAGGCTGGAGTATAAGCAGGAGTCAGGGCAAGGAAAAACCAGAAGGGGTGGCTAACCAGGAGGCCACTGCAGGAGGAACAAAGGGCCTGGTCTTGGAGTGATGGGAACGGGGTGGACAGGTAAGGACAGAATCTGAGAGCGTGCAGAGGTGGATTCGGAACTGCCAGCAGGTTAGTAGTAGGGCAGGAAGGGCTTAGGCTGCCAAGGCATTGTGCCGTGGTAACCAAGAGCTTGGTGGTGCCACGGATCATGGGTTCA... | GGTTATCACTGGAAACCTATGGGGGATTTGGACGGGGATGACCACAGTTCTCTGGGAGAGTGAAGGCTGGAGTATAAGCAGGAGTCAGGGCAAGGAAAAACCAGAAGGGGTGGCTAACCAGGAGGCCACTGCAGGAGGAACAAAGGGCCTGGTCTTGGAGTGATGGGAACGGGGTGGACAGGTAAGGACAGAATCTGAGAGCGTGCAGAGGTGGATTCGGAACTGCCAGCAGGTTAGTAGTAGGGCAGGAAGGGCTTAGGCTGCCAAGGCATTGTGCCGTGGTAACCAAGAGCTTGGTGGTGCCACGGATCATGGGTTCA... |
Task1_train_13192 | The gene STXBP1 (syntaxin binding protein 1) on Chromosome 9 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; Severe global developmental delay | GGTTATCACTGGAAACCTATGGGGGATTTGGACGGGGATGACCACAGTTCTCTGGGAGAGTGAAGGCTGGAGTATAAGCAGGAGTCAGGGCAAGGAAAAACCAGAAGGGGTGGCTAACCAGGAGGCCACTGCAGGAGGAACAAAGGGCCTGGTCTTGGAGTGATGGGAACGGGGTGGACAGGTAAGGACAGAATCTGAGAGCGTGCAGAGGTGGATTCGGAACTGCCAGCAGGTTAGTAGTAGGGCAGGAAGGGCTTAGGCTGCCAAGGCATTGTGCCGTGGTAACCAAGAGCTTGGTGGTGCCACGGATCATGGGTTCA... | GGTTATCACTGGAAACCTATGGGGGATTTGGACGGGGATGACCACAGTTCTCTGGGAGAGTGAAGGCTGGAGTATAAGCAGGAGTCAGGGCAAGGAAAAACCAGAAGGGGTGGCTAACCAGGAGGCCACTGCAGGAGGAACAAAGGGCCTGGTCTTGGAGTGATGGGAACGGGGTGGACAGGTAAGGACAGAATCTGAGAGCGTGCAGAGGTGGATTCGGAACTGCCAGCAGGTTAGTAGTAGGGCAGGAAGGGCTTAGGCTGCCAAGGCATTGTGCCGTGGTAACCAAGAGCTTGGTGGTGCCACGGATCATGGGTTCA... |
Task1_train_13193 | A variant affecting Chromosome 9, within the gene STXBP1 (syntaxin binding protein 1), has been observed. Determine if it's benign or associated with disease. | Pathogenic; Microcephaly | GGTTATCACTGGAAACCTATGGGGGATTTGGACGGGGATGACCACAGTTCTCTGGGAGAGTGAAGGCTGGAGTATAAGCAGGAGTCAGGGCAAGGAAAAACCAGAAGGGGTGGCTAACCAGGAGGCCACTGCAGGAGGAACAAAGGGCCTGGTCTTGGAGTGATGGGAACGGGGTGGACAGGTAAGGACAGAATCTGAGAGCGTGCAGAGGTGGATTCGGAACTGCCAGCAGGTTAGTAGTAGGGCAGGAAGGGCTTAGGCTGCCAAGGCATTGTGCCGTGGTAACCAAGAGCTTGGTGGTGCCACGGATCATGGGTTCA... | GGTTATCACTGGAAACCTATGGGGGATTTGGACGGGGATGACCACAGTTCTCTGGGAGAGTGAAGGCTGGAGTATAAGCAGGAGTCAGGGCAAGGAAAAACCAGAAGGGGTGGCTAACCAGGAGGCCACTGCAGGAGGAACAAAGGGCCTGGTCTTGGAGTGATGGGAACGGGGTGGACAGGTAAGGACAGAATCTGAGAGCGTGCAGAGGTGGATTCGGAACTGCCAGCAGGTTAGTAGTAGGGCAGGAAGGGCTTAGGCTGCCAAGGCATTGTGCCGTGGTAACCAAGAGCTTGGTGGTGCCACGGATCATGGGTTCA... |
Task1_train_13194 | This variant affects the gene STXBP1 (syntaxin binding protein 1) found on Chromosome 9. What is the clinical effect of this variant — benign or pathogenic? State the disease if applicable. | Pathogenic; Developmental and epileptic encephalopathy, 4 | CTCCTTTACAAGAGGGGTTCGCTAGGTGGAGAAGCCGGAGTTGGCTGGGTGGCTTGTGAAGCATCTCCCTGTTTTCCCCCAGGGCCCAGACAAGGCACGCTCCCAGCTCCTGATCCTGGATCGAGGCTTTGACCCCAGCTCCCCTGTGCTCCATGAATTGACTTTTCAGGCTATGAGTTATGATCTGCTGCCTATCGAAAATGATGTATACAAGTAAGTATAGTGTTACAGACCCCAGAGTGTATACGGCTCTGCACATGAGCCAAAAATATGTCTAGAAAAAGAACGGGTTTTTTTGTTTGTTTGTTTTGAGATGGAGT... | CTCCTTTACAAGAGGGGTTCGCTAGGTGGAGAAGCCGGAGTTGGCTGGGTGGCTTGTGAAGCATCTCCCTGTTTTCCCCCAGGGCCCAGACAAGGCACGCTCCCAGCTCCTGATCCTGGATCGAGGCTTTGACCCCAGCTCCCCTGTGCTCCATGAATTGACTTTTCAGGCTATGAGTTATGATCTGCTGCCTATCGAAAATGATGTATACAAGTAAGTATAGTGTTACAGACCCCAGAGTGTATACGGCTCTGCACATGAGCCAAAAATATGTCTAGAAAAAGAACGGGTTTTTTTGTTTGTTTGTTTTGAGATGGAGT... |
Task1_train_13195 | A mutation on Chromosome 9 affecting STXBP1 (syntaxin binding protein 1) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Early infantile epileptic encephalopathy with suppression bursts | CTCCTTTACAAGAGGGGTTCGCTAGGTGGAGAAGCCGGAGTTGGCTGGGTGGCTTGTGAAGCATCTCCCTGTTTTCCCCCAGGGCCCAGACAAGGCACGCTCCCAGCTCCTGATCCTGGATCGAGGCTTTGACCCCAGCTCCCCTGTGCTCCATGAATTGACTTTTCAGGCTATGAGTTATGATCTGCTGCCTATCGAAAATGATGTATACAAGTAAGTATAGTGTTACAGACCCCAGAGTGTATACGGCTCTGCACATGAGCCAAAAATATGTCTAGAAAAAGAACGGGTTTTTTTGTTTGTTTGTTTTGAGATGGAGT... | CTCCTTTACAAGAGGGGTTCGCTAGGTGGAGAAGCCGGAGTTGGCTGGGTGGCTTGTGAAGCATCTCCCTGTTTTCCCCCAGGGCCCAGACAAGGCACGCTCCCAGCTCCTGATCCTGGATCGAGGCTTTGACCCCAGCTCCCCTGTGCTCCATGAATTGACTTTTCAGGCTATGAGTTATGATCTGCTGCCTATCGAAAATGATGTATACAAGTAAGTATAGTGTTACAGACCCCAGAGTGTATACGGCTCTGCACATGAGCCAAAAATATGTCTAGAAAAAGAACGGGTTTTTTTGTTTGTTTGTTTTGAGATGGAGT... |
Task1_train_13196 | This variant affects the gene STXBP1 (syntaxin binding protein 1) found on Chromosome 9. What is the clinical effect of this variant — benign or pathogenic? State the disease if applicable. | Pathogenic; Infantile epilepsy syndrome | GAGAAGCCGGAGTTGGCTGGGTGGCTTGTGAAGCATCTCCCTGTTTTCCCCCAGGGCCCAGACAAGGCACGCTCCCAGCTCCTGATCCTGGATCGAGGCTTTGACCCCAGCTCCCCTGTGCTCCATGAATTGACTTTTCAGGCTATGAGTTATGATCTGCTGCCTATCGAAAATGATGTATACAAGTAAGTATAGTGTTACAGACCCCAGAGTGTATACGGCTCTGCACATGAGCCAAAAATATGTCTAGAAAAAGAACGGGTTTTTTTGTTTGTTTGTTTTGAGATGGAGTCTCGCTCTGTCACCCAAGCGGGAGTGCA... | GAGAAGCCGGAGTTGGCTGGGTGGCTTGTGAAGCATCTCCCTGTTTTCCCCCAGGGCCCAGACAAGGCACGCTCCCAGCTCCTGATCCTGGATCGAGGCTTTGACCCCAGCTCCCCTGTGCTCCATGAATTGACTTTTCAGGCTATGAGTTATGATCTGCTGCCTATCGAAAATGATGTATACAAGTAAGTATAGTGTTACAGACCCCAGAGTGTATACGGCTCTGCACATGAGCCAAAAATATGTCTAGAAAAAGAACGGGTTTTTTTGTTTGTTTGTTTTGAGATGGAGTCTCGCTCTGTCACCCAAGCGGGAGTGCA... |
Task1_train_13197 | Consider this mutation in STXBP1 (syntaxin binding protein 1) on Chromosome 9. Is this a benign change or a disease-causing variant? | Pathogenic; Inborn genetic diseases | GAGAAGCCGGAGTTGGCTGGGTGGCTTGTGAAGCATCTCCCTGTTTTCCCCCAGGGCCCAGACAAGGCACGCTCCCAGCTCCTGATCCTGGATCGAGGCTTTGACCCCAGCTCCCCTGTGCTCCATGAATTGACTTTTCAGGCTATGAGTTATGATCTGCTGCCTATCGAAAATGATGTATACAAGTAAGTATAGTGTTACAGACCCCAGAGTGTATACGGCTCTGCACATGAGCCAAAAATATGTCTAGAAAAAGAACGGGTTTTTTTGTTTGTTTGTTTTGAGATGGAGTCTCGCTCTGTCACCCAAGCGGGAGTGCA... | GAGAAGCCGGAGTTGGCTGGGTGGCTTGTGAAGCATCTCCCTGTTTTCCCCCAGGGCCCAGACAAGGCACGCTCCCAGCTCCTGATCCTGGATCGAGGCTTTGACCCCAGCTCCCCTGTGCTCCATGAATTGACTTTTCAGGCTATGAGTTATGATCTGCTGCCTATCGAAAATGATGTATACAAGTAAGTATAGTGTTACAGACCCCAGAGTGTATACGGCTCTGCACATGAGCCAAAAATATGTCTAGAAAAAGAACGGGTTTTTTTGTTTGTTTGTTTTGAGATGGAGTCTCGCTCTGTCACCCAAGCGGGAGTGCA... |
Task1_train_13198 | This mutation occurs in STXBP1 (syntaxin binding protein 1) on Chromosome 9. Does this change lead to a known medical condition, or is it benign? | Pathogenic; Developmental and epileptic encephalopathy, 4 | CAGATCATCAGCCCCACAGGCCTCTCTCTGGTCTCATCTCTGCCCCTATCCTTGTTGCCCTGCCTCCTTGCTCCAGCCACACCAGTGTCCTCTTGCCTCAGACCTGGCCAGGTTCTTTGGCTCAGGCATCATTTCCTCAGGGAAACCCTCCCCGGGTCCCTACCCAGACTAGGCAGATGCCTGTGCCACGTGCACCCACACTACCTGGTGAGTCCCCTCGAAGGGCCCTGATCTCTGCAGTGCTTTGGCTCCTCTCCTGGATGCTCTGATTCTCCGTGAATTAGAGATTCTTTTTTTTTTTTCTTTTGTCCTTGTATCTC... | CAGATCATCAGCCCCACAGGCCTCTCTCTGGTCTCATCTCTGCCCCTATCCTTGTTGCCCTGCCTCCTTGCTCCAGCCACACCAGTGTCCTCTTGCCTCAGACCTGGCCAGGTTCTTTGGCTCAGGCATCATTTCCTCAGGGAAACCCTCCCCGGGTCCCTACCCAGACTAGGCAGATGCCTGTGCCACGTGCACCCACACTACCTGGTGAGTCCCCTCGAAGGGCCCTGATCTCTGCAGTGCTTTGGCTCCTCTCCTGGATGCTCTGATTCTCCGTGAATTAGAGATTCTTTTTTTTTTTTCTTTTGTCCTTGTATCTC... |
Task1_train_13199 | The variant affects gene STXBP1 (syntaxin binding protein 1), which is on Chromosome 9. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; Inborn genetic diseases | GTTTCAACATTATAAAACCATGGTTCAAATTCTAAGCGAAGAGAAGATGTTAAAAGATTCTGAAGCCGGCTGGGCGTGGTGGCTCACGCCTGTAATTCCAGCACTTTGGGAGGCCGAGACGGGCGGATCATGAAGTCAGGAGTTCAAGACCAGCTTGGGCAACACAGTGAAACCCCATCTCTACTAAAAATACAAAAATTAATTGGGCGTGGTAGCTGGCGCCTGTAATCCCAGCTACTTGGGGGGCTGAGGCAGGAGAATCGCTCGAACTCGGGAGGCGGAGGTTGCAGTGAACAGAGATTGCTCCACTGCACTCCAGC... | GTTTCAACATTATAAAACCATGGTTCAAATTCTAAGCGAAGAGAAGATGTTAAAAGATTCTGAAGCCGGCTGGGCGTGGTGGCTCACGCCTGTAATTCCAGCACTTTGGGAGGCCGAGACGGGCGGATCATGAAGTCAGGAGTTCAAGACCAGCTTGGGCAACACAGTGAAACCCCATCTCTACTAAAAATACAAAAATTAATTGGGCGTGGTAGCTGGCGCCTGTAATCCCAGCTACTTGGGGGGCTGAGGCAGGAGAATCGCTCGAACTCGGGAGGCGGAGGTTGCAGTGAACAGAGATTGCTCCACTGCACTCCAGC... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.